Rank	Title	Status	Study Results	Conditions	Interventions	Locations	URL
1	In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria	Completed	No Results Available	MALARIA, FALCIPARUM	Drug: artemether-lumefantrine (AL)|Drug: artesunate-amodiaquine (ASAQ)	Malaria Alert Center, University of Malawi College of Medicine, Blantyre, Malawi, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT02637128
2	Methylene Blue Against Falciparum Malaria in Burkina Faso	Completed	No Results Available	Malaria, Falciparum	Drug: Methylene Blue|Drug: Primaquine	CRSN, Nouna, Burkina Faso	https://ClinicalTrials.gov/show/NCT02851108
3	A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria	Completed	No Results Available	Malaria,Falciparum	Drug: Eurartesim dispersible oral tablet|Drug: eurartesim film coated tablet	Centre Muraz, Bobo Dioulasso, Burkina Faso|Centre National de Recherche et de Formation en Paludisme, Ouagadougou, Burkina Faso|Kinshasa School of Public Health, School of Medicine, University of Kinshasa, Kinshasa, Congo, The Democratic Republic of the|Medical Research Council, Fajara, Gambia|Manica's Health Research Centre, Manica, Mozambique|Bagamoyo Research center, Ifakara Heath Institute, Bagamoyo, Tanzania|National Insititute for Medical Research, Tanga, Tanzania	https://ClinicalTrials.gov/show/NCT01992900
4	Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi	Completed	No Results Available	Malaria, Falciparum	Drug: Amodiaquine plus artesunate|Drug: chlorproguanil-dapsone plus artesunate	Kawale Health Center, Lilongwe, Lilongwe District, Malawi|Machinga District Hospital, Liwonde, Machinga District, Malawi|Matiki Health Center, Dwangwa, Nkhotakota District, Malawi	https://ClinicalTrials.gov/show/NCT00164359
5	Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: Pyronaridine-artesunate	Tasanh Health Centre, Battambang, Battambang, Cambodia|Referral hospital (Pailin), Pailin, Cambodia|Promoy Health Centre (Pursat), Pursat), Cambodia	https://ClinicalTrials.gov/show/NCT02389439
6	Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa	Completed	Has Results	Malaria, Falciparum	Drug: Azithromycin plus Chloroquine|Drug: Artemether-lumefantrine	Pfizer Investigational Site, Nouna, Burkina Faso|Pfizer Investigational Site, Ouagadougou 01, Burkina Faso|Pfizer Investigational Site, Ouagadougou, Burkina Faso|Pfizer Investigational Site, Abidjan 13, Côte D'Ivoire|Pfizer Investigational Site, Navrongo, Ghana|Pfizer Investigational Site, Kisumu, Kenya|Pfizer Investigational Site, Bamako, West Africa, Mali|Pfizer Investigational Site, Sikasso, West Africa, Mali	https://ClinicalTrials.gov/show/NCT00677833
7	Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia	Completed	No Results Available	Malaria, Falciparum	Drug: Dihydroartemisinin-Piperaquine|Drug: Artemether-lumefantrine	Primary health centres, Kuala Langkat, North Sumatera, Indonesia|Primary health centres, Tanjung Tiram, North Sumatera, Indonesia|Pulau-pulau Batu health centres, Tello island, North Sumatera, Indonesia	https://ClinicalTrials.gov/show/NCT02325180
8	Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria	Terminated	No Results Available	Malaria, Falciparum	Drug: Sevuparin sodium + atovaquone/proquanil|Drug: atovaquone/proquanil	Mae Ramat Hospital, Mae Ramat, Tak province, Thailand|Maesot General hospital, Mae Sot, Tak Province, Thailand|Hospital for Tropical Diseases, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT01442168
9	Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: Artemether/lumefantrine tablets|Drug: Artemether/Lumefantrine suspension	Chulaimbo Health Centre, Kisumu, Nyanza, Kenya	https://ClinicalTrials.gov/show/NCT00529867
10	Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi	Completed	No Results Available	Malaria, Falciparum	Drug: Artemether-lumefantrine combination|Drug: Artesunate-amodiaquine combination|Drug: Dihydroartemisinin-piperaquine	Machinga District Hospital, Liwonde, Malawi	https://ClinicalTrials.gov/show/NCT01326754
11	Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan	Completed	No Results Available	Malaria, Falciparum	Drug: Chloroquine	Adezai Basic Health Unit, Adezai, Nwfp, Pakistan|Baghicha Basic Health Unit, Baghicha, Nwfp, Pakistan|Kagan Basic Health Unit, Kagan, Nwfp, Pakistan	https://ClinicalTrials.gov/show/NCT01019408
12	Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: intravenous (IV) arginine	RSMM Hospital, Timika, Indonesia	https://ClinicalTrials.gov/show/NCT00147368
13	Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America	Completed	No Results Available	Malaria, Falciparum	Drug: Azithromycin/Chloroquine|Drug: Atovaquone/Proguanil		https://ClinicalTrials.gov/show/NCT00084227
14	Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia	Terminated	No Results Available	Malaria, Falciparum	Drug: Azithromycin/Chloroquine|Drug: Sulfadoxine-Pyrimethamine/Chloroquine		https://ClinicalTrials.gov/show/NCT00084240
15	Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam	Recruiting	No Results Available	Malaria, Falciparum	Drug: ACT|Drug: TACT	Siem Pang Health Center, Siem Pang, Stung Treng, Cambodia|Pailin Referral Hospital, Pailin, Cambodia|Hospital for Tropical Diseases of Khanh Hoa,, Van Ninh, Khanh Hoa, Vietnam|Phuoc Long Hospital, Phuoc Long, Phuoc, Vietnam	https://ClinicalTrials.gov/show/NCT03355664
16	Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria	Completed	No Results Available	Falciparum Malaria	Drug: artesunate plus sulfadoxine-pyrimethamine (AS+SP)	Provincial Malaria Control Centers (MRC), Maimana, Faryab, Afghanistan|Provincial Malaria Control Centers (MRC), Asadabad, Kunar, Afghanistan|Provincial Malaria Control Centers (MRC), Jalalabad, Nangarhar, Afghanistan|Provincial Malaria Control Centers (MRC), Taloqan, Afghanistan	https://ClinicalTrials.gov/show/NCT01115439
17	VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine	Recruiting	No Results Available	Malaria,Falciparum	Biological: Pfs25-IMX313/Matrix-M1	CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom	https://ClinicalTrials.gov/show/NCT04130282
18	Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria	Suspended	No Results Available	Severe Falciparum Malaria	Drug: L-arginine hydrochloride|Other: Normal saline	Mitra Masyarakat Hospital, Timika, Papua, Indonesia	https://ClinicalTrials.gov/show/NCT00616304
19	Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria	Unknown status	No Results Available	Uncomplicated Falciparum Malaria	Drug: AM(FDC)|Drug: AM(LT)|Drug: AL|Drug: DP|Drug: AA(FDC)	Dabhine and Mingan Clinic, Sittwe, Rakhine, Myanmar|Myit Kyi Nar Clinic, Kachin, Myanmar|Myothugyi Rural Health Center, Bu Thee Daung, Maungdaw, Myanmar|Lashio Clinic, Shan, Myanmar	https://ClinicalTrials.gov/show/NCT00902811
20	A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)	Completed	No Results Available	Malaria, Falciparum	Drug: ACT|Drug: TACT	College of Medicine Chittagong, Ramu, Bangladesh|Pailin, Pailin, Cambodia|Preah Vihear, Preah Vihear, Cambodia|Pursat, Pursat, Cambodia|Ratanakiri, Ratankiri, Cambodia|Kinshasa, Kinshasa, Congo, The Democratic Republic of the|Mohanpur Community health center, Agartala, India|Midnapore, Midnapore, India|Ispat General hospital, Rourkela, India|Sekong, Sekong, Lao People's Democratic Republic|Ann Hospital, Ann, Myanmar|Pyay hospital, Pyay, Myanmar|Pyin oo Lwin hospital, Pyin oo Lwin, Myanmar|Thabeikkyin hospital, Thabeikkyin, Myanmar|Phusing hospital, Phusing, Srisaket, Thailand|Tha Song Yang hospital, Tha Song Yang, Tak, Thailand|Chumphon hospital, Chumphon, Thailand|Kunhan Hospital, Si Sa Ket, Thailand|Thanto Hospital, Yala, Thailand|Binh Phuoc hospital, Binh Phuoc, Vietnam	https://ClinicalTrials.gov/show/NCT02453308
21	Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: ASAQ Winthrop® Sanofi Aventis|Drug: Coartem®, Novartis	General reference hospital of Chamfubu, Pweto, Katanga, Congo, The Democratic Republic of the	https://ClinicalTrials.gov/show/NCT01567423
22	Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity	Completed	No Results Available	Malaria, Falciparum|Plasmodium Falciparum		Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT01160562
23	Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia	Withdrawn	No Results Available	Uncomplicated Falciparum Malaria	Drug: Artemisone/Mefloquine (AmiM3)|Drug: Artesunate	Pailin Hospital, Pailin, Cambodia	https://ClinicalTrials.gov/show/NCT00936767
24	Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in Zanzibar	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artesunate-amodiaquine given with single low dose primaquine	Micheweni, Bububu Jesheni, and Uzini, Zanzibar, Tanzania	https://ClinicalTrials.gov/show/NCT03773536
25	Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artemether-lumefantrine|Drug: Artesunate + Amodiaquine		https://ClinicalTrials.gov/show/NCT03768908
26	Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania	Completed	No Results Available	Uncomplicated Falciparum Malaria	Drug: Artesunate amodiaquine	National Institute for Medical Research, Tanga, Tanzania	https://ClinicalTrials.gov/show/NCT03431714
27	Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali	Completed	No Results Available	Accute Falciparum Malaria		Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT02645604
28	Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda	Completed	No Results Available	Falciparum Malaria	Drug: Primaquine	Walukuba Health Centre IV, Jinja, Eastern Region, Uganda	https://ClinicalTrials.gov/show/NCT01365598
29	Imatinib's Effect on the Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria	Unknown status	No Results Available	Plasmodium Falciparum Malaria	Drug: Imatinib|Drug: Dihydroartemisinin-piperaquine	A Tuc, Huong Hoa, Quang Tri, Vietnam	https://ClinicalTrials.gov/show/NCT02614404
30	Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.	Completed	Has Results	Uncomplicated Plasmodium Falciparum Malaria	Drug: Artefenomel 800mg: piperaquine 640mg|Drug: Artefenomel 800mg: piperaquine 960mg|Drug: Artefenomel 800mg: piperaquine 1440mg	Centre D'Étude Et de Recherchesur Le Paludisme Associé À La Grossesse Et À L'Enfance (Cerpage) Cerpage, Cotonou, Benin|Centre National de Recherche et de Formation sur le paludisme (CNRFP) Ouagadougou, Kadiogo, Ouagadougou, Burkina Faso|Clinical research Unit of Nanoro (CRUN)/CMA Saint Camille de Nanoro, 11 BP 218 Ouagadougou CMS 11, Ouagadougou, Burkina Faso|Kinshasa School of Public Health, School of Medicine University of Kinshasa, Kinshasa, Congo, The Democratic Republic of the|Centre de Recherches Medicales de Lambarene, Albert Schweitzer Hospital, Lambarene, Gabon|arielle K. Bouyou-Akotet, Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Université des Sciences de la Santé, BP 4009, Libreville, Gabon, Libreville, Gabon|MANHIÇA HEALTH RESEARCH CENTER, Rua 12, Vila da Manhica, Maputa,, Chefe Maputa, Mozambique|Tororo District Hospital, Tororo, Uganda|National Institute of Malariology, Parasitology and Entomology, 245 Luong The Vinh Street, Trung van, Tu Liem, Hanoi, Vietnam, Hanoi, Vietnam	https://ClinicalTrials.gov/show/NCT02083380
31	Randomized Trial on Effectiveness of ACTs in Ghana	Terminated	No Results Available	Malaria, Falciparum	Drug: Artesunate plus Amodiaquine|Drug: Artemether-Lumefantrine	Agogo Presbyterian Hospital, Agogo, Asante Akim North District, Ghana	https://ClinicalTrials.gov/show/NCT00374205
32	Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: chlorproguanil-dapsone-artesunate|Drug: chlorproguanil-dapsone	GSK Investigational Site, Ouagadougou, Burkina Faso|GSK Investigational Site, Kumasi, Ghana|GSK Investigational Site, Bamako, Mali|GSK Investigational Site, Ile-Ife, Nigeria|GSK Investigational Site, Jos, Nigeria|GSK Investigational Site, Lagos, Nigeria|GSK Investigational Site, Maiduguri, Nigeria	https://ClinicalTrials.gov/show/NCT00371735
33	Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum	Completed	No Results Available	Falciparum Malaria	Drug: artesunate & mefloquine combination	Oswaldo Cruz Foundation, Rio de Janeiro, Brazil|Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil	https://ClinicalTrials.gov/show/NCT01144702
34	Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: chlorproguanil-dapsone-artesunate|Drug: artemether-lumefantrine	GSK Investigational Site, Bobo-Dioulasso, Burkina Faso|GSK Investigational Site, Kintampo, Ghana|GSK Investigational Site, Eldoret, Kenya|GSK Investigational Site, Kilifi, Kenya|GSK Investigational Site, Barkin Ladi, Nigeria|GSK Investigational Site, Calabar, Nigeria|GSK Investigational Site, Enugu, Nigeria|GSK Investigational Site, Ibadan, Nigeria|GSK Investigational Site, Ifakara, Tanzania	https://ClinicalTrials.gov/show/NCT00344006
35	Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia	Completed	No Results Available	Acute Falciparum Malaria	Drug: Dihydroartemisinin-piperaquine (DHA-PPQ)|Drug: Mefloquine (MQ)	National Center for Parasitology, Entomology, and Malaria Controk, Ministry of H, Phnom Penh, Cambodia	https://ClinicalTrials.gov/show/NCT02612545
36	A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: FMP2.1/AS01B	NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton, Southampton, Hampshire, United Kingdom|Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom|NIHR Wellcome Trust Clinical Research Facility (NIHR WTCRF), Hammersmith Hospital, London, United Kingdom	https://ClinicalTrials.gov/show/NCT02044198
37	Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa	Completed	No Results Available	Malaria, Falciparum	Drug: Azithromycin/Chloroquine|Drug: Mefloquine	Pfizer Investigational Site, Navrongo, Ghana|Pfizer Investigational Site, Bamako, Mali|Pfizer Investigational Site, Jinja, Uganda|Pfizer Investigational Site, Kampala, Uganda|Pfizer Investigational Site, Ndola, Zambia|Pfizer Investigational Site	https://ClinicalTrials.gov/show/NCT00082576
38	Fetal Immunity to Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria		KEMRI Centre for Geographic Medicine Research, Nairobi, Kenya	https://ClinicalTrials.gov/show/NCT00314899
39	Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: pyronaridine/artesunate	Pailin General Hospital, Pailin, Cambodia|Farafenni Field Station, c/o MRC Laboratories, Faraffeni, Gambia|Bethesday Hospital, Tomohon, North Sulawesi, Indonesia|Centre de santé du roi Baudoin, Guediawaye, Senegal|Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|MSF Epicentre, Mbarara, Uganda	https://ClinicalTrials.gov/show/NCT01594931
40	Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh	Completed	No Results Available	Uncomplicated Falciparum Malaria	Drug: azithromycin plus artesunate|Drug: Artesunate	Sadar Hospital, Bandarban, Bangladesh	https://ClinicalTrials.gov/show/NCT00356005
41	Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Co-Arinate FDC|Drug: Coartem	Cameroon Baptist Convention Clinic of Biyem-Assi, Yaounde, Cameroon|Health centres of Samako, Kolle and Bancoumane, Bamako, Mali|Health centres Rwamagana and Muhima, Kigali, Rwanda|Alhara Alola Health centre, New Halfa, Sudan	https://ClinicalTrials.gov/show/NCT00484900
42	EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Placebo|Biological: EP-1300	Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States	https://ClinicalTrials.gov/show/NCT01169077
43	SP Resistance and Falciparum Malaria Transmission	Withdrawn	No Results Available	Plasmodium Falciparum Malaria	Drug: sulfadoxine/pyrimethamine	Malaria Vaccine and Drug Development Center, Cali, Colombia|Universidad del Valle Sede San Fernando, Cali, Colombia	https://ClinicalTrials.gov/show/NCT00299247
44	A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria	Completed	Has Results	Falciparum Malaria	Drug: Azithromycin plus chloroquine	Pfizer Investigational Site, San Andres de Tumaco, Narino, Colombia|Pfizer Investigational Site, Bambolim, Goa, India	https://ClinicalTrials.gov/show/NCT00282919
45	Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission	Completed	No Results Available	Malaria,Falciparum	Drug: Pyronaridine Tetraphosphate/Artesunate|Drug: Dihydroartemisinin/Piperaquine|Drug: Primaquine Diphosphate	Malaria Research and Training Centre, Bamako, Mali|Radboud university medical center, Nijmegen, Netherlands	https://ClinicalTrials.gov/show/NCT04049916
46	Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria	Completed	No Results Available	Severe Falciparum Malaria		Chittagong Medical College Hospital, Chittagong, Bangladesh	https://ClinicalTrials.gov/show/NCT00692627
47	Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon	Completed	No Results Available	Malaria, Vivax|Malaria, Falciparum	Drug: Pyrimethamine/sulfdoxine (Fansidar)	Naval Medical Research Center Detachment, Lima, Peru	https://ClinicalTrials.gov/show/NCT00951106
48	Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria	Recruiting	No Results Available	Acute Uncomplicated Plasmodium Falciparum Malaria	Drug: KAF156 and LUM-SDF|Drug: Coartem	Novartis Investigative Site, Nanoro, Burkina Faso|Novartis Investigative Site, Lambarene, Gabon|Novartis Investigative Site, Banjul, Gambia|Novartis Investigative Site, Kombewa, Kenya|Novartis Investigative Site, Siaya, Kenya|Novartis Investigative Site, Sotuba, Mali|Novartis Investigative Site, Chokwe, Mozambique|Novartis Investigative Site, Ratchabari, Thailand|Novartis Investigative Site, Tak, Thailand|Novartis Investigative Site, Masaka, Uganda|Novartis Investigative Site, Tororo, Uganda|Novartis Investigative Site, Binh Phuoc Province, VNM, Vietnam|Novartis Investigative Site, Ho Chi Minh, Vietnam	https://ClinicalTrials.gov/show/NCT03167242
49	Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in Tanzania	Completed	No Results Available	Malaria,Falciparum	Biological: ChAd63 RH5|Biological: MVA RH5|Biological: Rabies Vaccine	Ifakara Health Institute Clinical Trial Facility, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT03435874
50	ICC-1132 - Candidate Vaccine Against P Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: Malaria ICC-1132|Biological: Alhydrogel	University of Maryland Baltimore, Baltimore, Maryland, United States	https://ClinicalTrials.gov/show/NCT00587249
51	"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"	Completed	No Results Available	Malaria,Falciparum	Drug: Artemether-Lumefantrine Tab 20-120mg|Drug: Primaquine Phosphate 0.25 mg/kg|Other: Placebo	Fukayosi Dispensary, Bagamoyo, Pwani, Tanzania|Yombo Dispensary, Bagamoyo, Yombo, Tanzania	https://ClinicalTrials.gov/show/NCT03241901
52	Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artemether-lumefantrine	Kemri-Wellcome Trust Programme, Kilifi, Kenya|University College Hospital Malaria Research Laboratories Institute for Advance Medical Research and Training, Ibadan, Nigeria|Muhimbili University College of Health Sciences Department of Parasitology and Medical Entomology, Box 65011, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT00709969
53	Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers	Completed	No Results Available	Malaria, Falciparum	Drug: Eurartesim™|Drug: Riamet®|Other: Placebo and finally Moxifloxacin	SGS aster s.a.s, Paris, France	https://ClinicalTrials.gov/show/NCT01103830
54	Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO	Completed	No Results Available	Plasmodium Falciparum|Malaria, Falciparum	Drug: artemisinin/naphthoquine|Drug: dihydroartemisinin/piperaquine phosphate	Ifakara Health Institute, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT01930331
55	Assessment of Artesunate/Mefloquine in the Peruvian Amazon	Unknown status	No Results Available	Malaria, Falciparum	Drug: Artesunate|Drug: Mefloquine	NAMRU 6, Iquitos, Loreto, Peru	https://ClinicalTrials.gov/show/NCT02084602
56	Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics	Unknown status	No Results Available	Malaria, Falciparum	Dietary Supplement: Food	Department of Pharmacology & Therapeutics, MakCHS, Mulago Hospital Complex, Kampala, Uganda	https://ClinicalTrials.gov/show/NCT01944189
57	Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria	Unknown status	No Results Available	Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria	Drug: Fosmidomycin-Piperaquine		https://ClinicalTrials.gov/show/NCT02198807
58	Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Mefloquine-artesunate	Centre Muraz, Nanoro, Burkina Faso	https://ClinicalTrials.gov/show/NCT00701961
59	Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar	Withdrawn	No Results Available	Uncomplicated Falciparum Malaria|Artemisinin-resistant	Drug: Arterolane maleate-piperaquine phosphate (Synriam)|Drug: Dihydroartemisinin-piperaquine phosphate (Duocotexin)		https://ClinicalTrials.gov/show/NCT02461186
60	Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria	Completed	No Results Available	Uncomplicated Plasmodium Falciparum Malaria	Drug: Pyronaridine-Artesunate	Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon	https://ClinicalTrials.gov/show/NCT00331136
61	Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers	Completed	No Results Available	Malaria, Falciparum	Drug: Eurartesim	CMAX, a division of IDT Australia Limited, Adelaide, Australia	https://ClinicalTrials.gov/show/NCT01222962
62	A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™	Completed	No Results Available	Malaria, Falciparum	Drug: Eurartesim	CMAX, a division of IDT Australia Limited, Adelaide, Australia|Nucleus Network Limited, Melbourne, Australia	https://ClinicalTrials.gov/show/NCT01222949
63	Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso	Completed	No Results Available	Uncomplicated P. Falciparum Malaria in Children	Drug: Artesunate-amodiaquine|Drug: Artemether-lumefantrine	Nanoro, Nanoro, Boulkiemdé, Burkina Faso|Nanoro, Nanoro, Boulkiemdé, Burkina Faso|IRSS-DRO/Centre Muraz, Bobo-Dioulasso, Bp 545, Burkina Faso|Tinto Halidou, Bobo-Dioulasso, Houet, Burkina Faso	https://ClinicalTrials.gov/show/NCT01017770
64	Controlled Human Malaria Infection Transmission Model - Phase A	Not yet recruiting	No Results Available	Malaria,Falciparum	Biological: PfSPZ Challenge|Drug: Sulfadoxine-Pyrimethamine|Drug: Piperaquine|Drug: Artemether lumefantrine|Drug: Primaquine	KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya	https://ClinicalTrials.gov/show/NCT04280692
65	Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.	Not yet recruiting	No Results Available	Malaria,Falciparum	Biological: Pfs25-IMX313/Matrix-M	Ifakara Health Institute Clinical Trial Facility, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT04271306
66	Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F	Recruiting	No Results Available	Malaria,Falciparum	Biological: TB31F	Radboud University Medical Center, Nijmegen, Gelderland, Netherlands	https://ClinicalTrials.gov/show/NCT04238689
67	Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin	Recruiting	No Results Available	Malaria,Falciparum	Drug: Sulfadoxine pyrimethamine + Amodiaquin|Drug: Dihydroartemisinin piperaquin	Ucrc - Usttb, Bamako, Select, Mali	https://ClinicalTrials.gov/show/NCT04149106
68	A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults	Not yet recruiting	No Results Available	Malaria,Falciparum	Biological: R21/Matrix-M|Biological: ChAd63/MVA ME-TRAP|Biological: intradermal injection (ID) or direct venous injection (DVI) of PfSPZ Challenge		https://ClinicalTrials.gov/show/NCT03947190
69	Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso	Recruiting	No Results Available	Malaria,Falciparum	Biological: R21 adjuvanted with 25mcg Matrix-M|Biological: Rabies Vaccine|Biological: R21 adjuvanted with 50mcg Matrix-M	Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso	https://ClinicalTrials.gov/show/NCT03896724
70	Bridging Trial to Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain 3D7 Within the WRAIR Controlled Human Malaria Infection (CHMI) Model	Active, not recruiting	No Results Available	Malaria,Falciparum	Biological: Plasmodium falciparum malaria parasite	Walter Reed Army Institute of Research, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT03882528
71	To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers	Recruiting	No Results Available	Malaria,Falciparum	Biological: 5 microgram VLPM01|Biological: 15 microgram VLPM01|Biological: 30 microgram VLPM01|Other: Plasmodium falciparum challenge	Walter Reed Army Institute of Research, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT03867331
72	Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections	Active, not recruiting	No Results Available	Malaria,Falciparum	Drug: Pyronaridine tetraphosphate 180mg:artesunate 60mg	MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine,, Fajara,, Banjul,, Gambia|Tropical Diseases Research Centre, Ndola, Zambia	https://ClinicalTrials.gov/show/NCT03814616
73	RBx11160 Phase II Dose Ranging Study RBx/MMV05-06	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Treatment with 3 dose groups of RBx11160 over 7 days	Field Station Malaria Reseach Centre (Indian Council of Medical Research), Rourkela, Orissa, India|Public Health Care Center, Kivunge, Zanzibar, Tanzania|District Hospital Bagamayo, Dar es Salaam, Tanzania|Faculty of Tropical Medicine, 420/6 Rajavithee Road, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT00362050
74	A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants	Recruiting	No Results Available	Malaria,Falciparum	Biological: R21 in Matrix- M adjuvant vaccine	KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast, Kilifi, Kenya	https://ClinicalTrials.gov/show/NCT03580824
75	Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum	Terminated	No Results Available	Malaria, Falciparum	Drug: Azithromycin/Chloroquine|Drug: Chloroquine		https://ClinicalTrials.gov/show/NCT00082563
76	Cohort Event Monitoring Study of Pyramax®	Completed	No Results Available	Malaria,Falciparum	Drug: pyronaridine artesunate	The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa, Yaoundé, Cameroon|Centre de Recherche du Centre Hospitalier du Mont Amba, Kinshasa, Congo, The Democratic Republic of the|Centre de Santé FCRM, Hospital of Talangai, Brazzaville, Congo|Institut Pierre Richet / Institut National de SanPublique (IPR/INSP), Bouaké, Côte D'Ivoire|CERMEL, Albert Schweitzer Hospital, Lambaréné, Gabon	https://ClinicalTrials.gov/show/NCT03201770
77	Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model	Withdrawn	No Results Available	Malaria,Falciparum	Drug: MMV390048	Institute of Tropical Medicine / Centre for Clinical Trials, Eberhard Karls University, Tübingen, Germany	https://ClinicalTrials.gov/show/NCT03195387
78	Artemisinin Resistance in Cambodia	Completed	No Results Available	Malaria, Falciparum	Drug: Artesunate	Tasanh Health Center, Tasanh, Batambang, Cambodia	https://ClinicalTrials.gov/show/NCT00479206
79	Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya	Completed	No Results Available	Malaria,Falciparum	Drug: Dihydroartemisinin-piperaquine		https://ClinicalTrials.gov/show/NCT02987270
80	A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607	Completed	No Results Available	Malaria, Falciparum	Drug: [14C]-GSK3191607	GSK Investigational Site, London, United Kingdom	https://ClinicalTrials.gov/show/NCT02737007
81	Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults	Completed	No Results Available	Malaria, Falciparum	Biological: Group A1 : 50µg AMA1-DiCo + Alhydrogel|Biological: Group A2 : 50 µg AMA1-DiCo+ GLA-SE|Biological: Group B2 : Placebo	CNRFP, Ouagadougou, Burkina Faso|CIC BT 505 de vaccinologie Cochin Pasteur, Hôpital Cochin Bâtiment Lavoisier 27 rue du faubourg St Jacqu, Paris, France	https://ClinicalTrials.gov/show/NCT02014727
82	Malaria Transmission Studies in Mali	Completed	No Results Available	Malaria, Falciparum		National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT01829737
83	Nitrite Infusion in Children With Malaria	Not yet recruiting	No Results Available	Falciparum Malaria	Drug: Sodium Nitrite	Hubert Kairuki Memorial University, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT04289558
84	Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis	Withdrawn	No Results Available	Malaria, Falciparum	Drug: Azithromycin capsules|Drug: Placebo|Biological: Immunization with falciparum	Leiden University Medical Centre, Leiden, Netherlands	https://ClinicalTrials.gov/show/NCT01783340
85	Experimental Vaccine for Plasmodium Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria|Vaccines	Drug: MSP1(42)-FVO & MSP1(42)-3D7	Quintiles Phase 1 Services, Lenexa, Kansas, United States	https://ClinicalTrials.gov/show/NCT00340431
86	Impact of Insecticide Resistance on Vector Control	Unknown status	No Results Available	Malaria, Falciparum	Other: Indoor residual insecticide spraying (IRS)|Device: Long Lasting Insecticidal Nets (LLIN)	Malaria Control Programme, Gedarif, Gedarif State, Sudan|Malaria Control Programme, Wad Medani, Gezira State, Sudan|Malaria Control Programme, Kassala, Kassala State, Sudan	https://ClinicalTrials.gov/show/NCT01713517
87	Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites	Completed	No Results Available	Malaria, Falciparum	Biological: Heterologous challenge|Drug: Malarone treatment	Leiden University Medical Centre, Leiden, Netherlands	https://ClinicalTrials.gov/show/NCT01660854
88	Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S	Completed	No Results Available	Malaria, Falciparum	Biological: FMP1/AS02|Biological: RTS,S/AS02|Other: AS02 adjuvant alone|Other: Malaria challenge	WRAIR Clinical Trials Center, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT01556945
89	Time to Become Negative of Three Rapid Diagnostic Tests for Malaria	Completed	No Results Available	Malaria, Falciparum		Kazo level 4 health centre, Kazo, Greater Mbarara District, Uganda|Mbarara Municipality level 2 health centre, Mbarara, Greater Mbarara district, Uganda	https://ClinicalTrials.gov/show/NCT01325974
90	DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria	Completed	No Results Available	Falciparum Malaria	Drug: DSM265 400mg|Drug: Placebo to DSM265 400 mg|Biological: Plasmodium falciparum sporozoite challenge|Drug: Malarone	Universitätsklinikum Tübingen, Institut für Tropenmedizin, Tübingen, Germany	https://ClinicalTrials.gov/show/NCT02450578
91	AMA1-C1/Alhydrogel + CpG 7909 for Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: AMA1-C1/Alhydrogel®|Biological: CPG 7909 Oligodeoxynucleotide (VaxImmune®)	University of Rochester, Rochester, New York, United States	https://ClinicalTrials.gov/show/NCT00344539
92	Study of Iron Absorption and Utilization in Asymptomatic Malaria	Completed	No Results Available	Malaria, Falciparum	Drug: Antimalarial treatment|Other: Observation	Hopital de zone de Natitingou, Natitingou, Benin	https://ClinicalTrials.gov/show/NCT01108939
93	Mass Screening and Treatment for Reduction of Falciparum Malaria	Recruiting	No Results Available	Plasmodium Falciparum Malaria	Diagnostic Test: Ultrasensitive Rapid Diagnostic Test (URDT)|Drug: Antimalarials	Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand	https://ClinicalTrials.gov/show/NCT04093765
94	Mass-Drug Administration to Reduce Malaria Transmission	Completed	No Results Available	Malaria, Falciparum	Drug: Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg)|Drug: Artesunate (day 1,2,3: 4 mg/kg)|Drug: Primaquine-base (day 3: 0.75 mg/kg)|Drug: placebo tablets	Kilimanjaro Christian Medical Centre, Moshi, Tanzania	https://ClinicalTrials.gov/show/NCT00509015
95	Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau	Completed	No Results Available	Malaria, Falciparum	Drug: Chloroquine|Drug: Artemether-lumefantrine (Coartem)	Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau	https://ClinicalTrials.gov/show/NCT00426439
96	Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine	Completed	No Results Available	Malaria, Falciparum	Biological: FMP1/AS02A	Walter Reed Project, Kombewa Clinic, City of Kisumu, Nyanza Province, Kenya	https://ClinicalTrials.gov/show/NCT00223990
97	Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi	Completed	No Results Available	Malaria, Falciparum	Drug: sulfadoxine-pyrimethamine|Drug: amodiaquine plus sulfadoxine-pyrimethamine|Drug: amodiaquine plus artesunate|Drug: chlorproguanil-dapsone plus artesunate|Drug: lumefantrine-artemether	Kawale Health Center, Lilongwe, Lilongwe District, Malawi|Machinga District Hospital, Liwonde, Machinga District, Malawi|Matiki Health Center, Dwangwa, Nkhotakota District, Malawi	https://ClinicalTrials.gov/show/NCT00164710
98	Preventing Malaria During Pregnancy in Epidemic-prone Areas.	Completed	No Results Available	Malaria, Falciparum	Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine|Device: Insecticide-treated mosquito bed net	Kabale District Health Services (antenatal clinics at selected sites), Kabale, Kabale District, Uganda	https://ClinicalTrials.gov/show/NCT00142207
99	The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children	Completed	No Results Available	Malaria, Falciparum	Drug: Sulfadoxine-pyrimethamine (Fansidar)	Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau	https://ClinicalTrials.gov/show/NCT00137553
100	Chloroquine and Amodiaquine for Treatment of Malaria in Children	Completed	No Results Available	Malaria, Falciparum	Drug: chloroquine|Drug: amodiaquine	Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau	https://ClinicalTrials.gov/show/NCT00137514
101	Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania	Completed	No Results Available	Malaria, Falciparum|HIV Infections	Drug: Artemether-lumefantrine (AL)	Muheza Designated District Hospital, Muheza, Tanga Region, Tanzania	https://ClinicalTrials.gov/show/NCT00885287
102	Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)	Active, not recruiting	No Results Available	Malaria,Falciparum	Drug: Proguanil Oral Tablet|Drug: Sulfadoxine/Pyrimethanine-Amodiaquine (SP-AQ)|Drug: Dihydroartemisinin-Piperaquine (DP)	Homa Bay County Referral Hospital, Homa Bay Town, Homa Bay County, Kenya	https://ClinicalTrials.gov/show/NCT03178643
103	Efficacy of ArTiMist™ in Children	Completed	Has Results	Falciparum Malaria	Drug: Quinine|Drug: Artemether		https://ClinicalTrials.gov/show/NCT01047436
104	Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artesunate|Drug: Mefloquine	Vector Borne Diseases Control Units (VBDC, malaria clinics), Borai, Khaosaming and Muang districts, Trat, Thailand	https://ClinicalTrials.gov/show/NCT01659281
105	MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants	Completed	No Results Available	Malaria, Falciparum	Drug: MMV390048 20mg|Drug: MMV390048 x mg|Drug: MMV390048 y mg	Q-Pharm Clinics, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia	https://ClinicalTrials.gov/show/NCT02281344
106	Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria	Completed	No Results Available	Falciparum Malaria	Drug: Rosiglitazone|Drug: Placebo	Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT00149383
107	Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artemether-lumefantrine|Drug: Coadministered Artesunate plus Amodiaquine		https://ClinicalTrials.gov/show/NCT03764527
108	Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials	Recruiting	No Results Available	Uncomplicated Falciparum Malaria	Drug: Artemether-lumefantrine|Drug: Dihydroartemisinin-piperaquine	Tropical Diseases Research Centre, Ndola, Copperbelt, Zambia	https://ClinicalTrials.gov/show/NCT04009343
109	Azithromycin Combination Therapy for the Treatment of Severe Malaria	Completed	No Results Available	Falciparum Malaria	Drug: Artesunate|Drug: Azithromycin + Artesunate	MARIB, Bandarban, Bangladesh	https://ClinicalTrials.gov/show/NCT01374126
110	Artemisinin-resistant Malaria in Cambodia	Completed	No Results Available	Plasmodium Falciparum Malaria		National Center for Parasitology, Entomology, and Malaria Controk, Ministry of H, Phnom Penh, Cambodia	https://ClinicalTrials.gov/show/NCT01736319
111	Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artemether-lumefantrine	Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT02089841
112	Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children	Completed	No Results Available	Uncomplicated Falciparum Malaria	Drug: artesunate (AS) - amodiaquine (AQ) - methylene blue (MB)	Nouna Health District, Nouna, Mouhoun, Burkina Faso	https://ClinicalTrials.gov/show/NCT01407887
113	Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.	Completed	No Results Available	Malaria, Falciparum	Drug: Intermittent preventive treatment (SP and amodiaquine)|Other: Placebo	Primary schools within Bondo district / Bondo District Hospital, Bondo, Bondo district, Kenya	https://ClinicalTrials.gov/show/NCT00142246
114	Superiority of ArTiMist Versus Quinine in Children With Severe Malaria	Completed	Has Results	Plasmodium Falciparum Malaria	Drug: Artemether Sublingual Spray|Drug: Quinine	Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso|Navrongo Health Research Centre, Navrongo, Ghana|Rwinkwavu District Hospital, Rwinkwavu, Eastern Province, Rwanda	https://ClinicalTrials.gov/show/NCT01258049
115	The Cytoadherence in Pediatric Malaria (CPM) Study	Completed	No Results Available	Plasmodium Falciparum Malaria		Mulago Hospital Acute Care Unit & Makerere University Department of Paediatrics & Child Health, Kampala, Uganda	https://ClinicalTrials.gov/show/NCT00707200
116	Compare the Effectiveness Between Existing Treatment and New Treatment	Completed	No Results Available	P. Falciparum Malaria	Drug: Mefloquine+Artesunate|Drug: Dihydroartemisinin-Piperaquine	Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand	https://ClinicalTrials.gov/show/NCT01640587
117	P. Falciparum Resistance to Artemisinin in Vietnam	Unknown status	No Results Available	Drug Resistant Malaria Due to Plasmodium Falciparum	Drug: Artesunate (AS) group|Drug: DHA - PPQ group	Chu R Cam commune, Pleiku, Gialai, Vietnam	https://ClinicalTrials.gov/show/NCT02604966
118	A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)	Not yet recruiting	No Results Available	Plasmodium Falciparum Malaria (Uncomplicated)	Drug: Artemether-lumefantrine+amodiaquine|Drug: Artemether-lumefantrine+placebo|Drug: Artesunate-piperaquine+mefloquine|Drug: Artesunate-piperaquine+placebo OR Artesunate-mefloquine		https://ClinicalTrials.gov/show/NCT03939104
119	A Study by the Development of Triple Artemisinin Combination Therapies (DeTACT) Collaboration (Africa)	Not yet recruiting	No Results Available	Plasmodium Falciparum Malaria (Uncomplicated)	Drug: Artemether-lumefantrine+ Amodiaquine (AL+AQ)|Drug: Artemether-lumefantrine + placebo (AL+PBO)|Drug: Artesunate-mefloquine+piperaquine (AS-MQ+PPQ)|Drug: Artesunate-mefloquine+placebo (AS-MQ+PBO)		https://ClinicalTrials.gov/show/NCT03923725
120	Trial of Artesunate Combination Therapy in Pakistan	Completed	No Results Available	Uncomplicated Falciparum Malaria	Drug: artesunate (AS)|Drug: sulphadoxine-pyrimethamine (SP)|Drug: Chloroquine (CQ)|Drug: primaquine (PQ)	HealthNet International, Peshawar, Pakistan	https://ClinicalTrials.gov/show/NCT00959517
121	Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia	Active, not recruiting	No Results Available	Malaria|Malaria, Falciparum	Drug: MDA with DHAp (Eurartesim)|Drug: Focal MDA with DHAp (Eurartesim)	Southern province medical office, Choma, Southern, Zambia	https://ClinicalTrials.gov/show/NCT02329301
122	Drug Combinations of Atovaquone-Proguanil (AP) With ACT	Recruiting	No Results Available	Plasmodium Falciparum Malaria (Drug Resistant)	Drug: Artesunate and Pyronaridine|Drug: Atovaquone Proguanil and Artesunate Pyronaridine|Drug: Atovaquone Proguanil and Artesunate Mefloquine	Kratie Referral Hospital, Kratie, Cambodia|Stung Treng Referral Hospital, Stung Treng, Cambodia|Anlong Veng Referral Hospital, Ânlóng Vêng, Cambodia	https://ClinicalTrials.gov/show/NCT03726593
123	Azithromycin Combination Therapy for Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Artesunate|Drug: Azithromycin|Drug: Quinine	Mahidol University Hospital for Tropical Diseases, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT00299208
124	Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg	Completed	Has Results	Acute Uncomplicated Falciparum Malaria	Drug: Artemether-lumefantrine (COA566)	Novartis Investigative Site, Cotonou, Benin|Novartis investigative site, Cotonou, Benin|Novartis Investigative Site, Burkina Faso, Burkina Faso|Novartis investigative site, Ouagadougou, Burkina Faso|Novartis investigative site, Kinshasa, Congo|Novartis investigative site, Calabar, Nigeria|Novartis investigative site, Lome, Togo	https://ClinicalTrials.gov/show/NCT01619878
125	Experimental Vaccine for Malaria in Adults in Mali	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: AMA1-C1|Drug: AMA1-C1/alhydrogel Malaria Vaccine	Malaria Research and Training Center (MRTC), Bamako, Mali	https://ClinicalTrials.gov/show/NCT00343005
126	Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status	Terminated	No Results Available	Plasmodium Falciparum Malaria	Drug: ARTEMETHER + LUMEFANTRINE VS. SULFADOXINE + PYRIMETHAMINE	Tropical Disease Research Center, Ndola, Cupperbelt, Zambia	https://ClinicalTrials.gov/show/NCT00304980
127	Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)	Completed	No Results Available	Malaria, Falciparum|Anemia	Device: Insecticide treated wall lining	Bomi County Health Team, Tubmanburg, Bomi County, Liberia	https://ClinicalTrials.gov/show/NCT02448745
128	SPK Study in Afghanistan	Unknown status	No Results Available	Uncomplicated P. Falciparum Malaria	Drug: Artesunate + Sulphadoxine-pyrimethamine	Narang, Asadabad, Watapoor district health centres, Kunar, Afghanistan	https://ClinicalTrials.gov/show/NCT01707199
129	Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India	Completed	No Results Available	PLASMODIUM FALCIPARUM MALARIA	Drug: Azithromycin/Chloroquine|Drug: Sulfadoxine-Pyrimethamine/Chloroquine	Pfizer Investigational Site, Dispur Guwahati, Assam, India|Pfizer Investigational Site, Bambolim, Gao, India|Pfizer Investigational Site, Nagpur, Maharashtra, India|Pfizer Investigational Site, Parel Mumbai, Maharashtra, India|Pfizer Investigational Site, Rourkela, Orissa, India|Pfizer Investigational Site, Vellore, Tamil Nadu, India|Pfizer Investigational Site, Indore, India	https://ClinicalTrials.gov/show/NCT00074841
130	Tracking Resistance to Artemisinin (TRAC)	Completed	No Results Available	Falciparum Malaria	Drug: Artesunate 2|Drug: Artesunate 4	Ramu Upazila Health Complex, Cox's Bazaar, Bangladesh|Pailin General Hospital, Pailin, Cambodia|District Referral Hospital, Preah Vihear, Cambodia|Pursat Referral Hospital, Pursat, Cambodia|District Referral Hospital, Rattanakiri, Cambodia|Kingasani Health Centre, Kinshasa, Congo, The Democratic Republic of the|Sulkapara Block Primary Health Center, West Bengal, India|Pingilikani Dispensary, Kilifi, Kenya|Phouvong District Hospital, Phouvong, Attapeu, Lao People's Democratic Republic|Myitkyina, Myitkyina, Kachin, Myanmar|Day Bu Noh, Luthaw, Karen, Myanmar|Pyin Oo Lwin, Mandalay, Mandalay Region, Myanmar|Thabeikkyin Hospital, Thabeikkyin, Mandalay, Myanmar|Shwe Kyin Hospital, Shwe Kyin, Myanmar|University of Ilorin Teaching Hospital, Ilorin, Nigeria|Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand|Kraburi Hospital, Ranong, Thailand|Phusing Hospital, Srisaket, Thailand|Phuoc Long Hospital, Binh Phuoc, Vietnam	https://ClinicalTrials.gov/show/NCT01350856
131	Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: Aluminum Phosphate|Drug: Placebo|Biological: EBA-175 RII-NG Malaria Vaccine	Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT00347555
132	Trial to Assess the Efficacy of Malaria Vaccine PfCS 102	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: PfCS102|Biological: Montanide ISA 720	Department of Ambulatory Care and Community Medicine; University Hospital, Lausanne, Switzerland	https://ClinicalTrials.gov/show/NCT01031524
133	Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.	Recruiting	No Results Available	Malaria	Drug: KAE609|Drug: Coartem	Novartis Investigative Site, Lambarene, Gabon|Novartis Investigative Site, Kintampo, Ghana|Novartis Investigative Site, Navrango, Ghana|Novartis Investigative Site, Bamako, Mali|Novartis Investigative Site, Sotuba, Mali|Novartis Investigative Site, Kigali, Rwanda|Novartis Investigative Site, Bushenyi, Uganda|Novartis Investigative Site, Kampala, Uganda|Novartis Investigative Site, Tororo, Uganda	https://ClinicalTrials.gov/show/NCT03334747
134	Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic	Completed	No Results Available	Plasmodium Falciparum Malaria	Diagnostic Test: Standard RDT and HS-RDT|Drug: Artemether-lumefantrine|Drug: Primaquine Phosphate	University of California, San Francisco, San Francisco, California, United States|Centre for Marialogy, Parasitology, and Entomology, Vientiane, Lao People's Democratic Republic	https://ClinicalTrials.gov/show/NCT03783299
135	Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania	Recruiting	No Results Available	Malaria,Falciparum|Anemia	Drug: Dihydroartemisinin-piperaquine|Drug: Artesunate-amodiaquine	National Institute for Medical Research, Tanga, Tanzania	https://ClinicalTrials.gov/show/NCT03640403
136	Safety and Tolerability of Low Dose Primaquine	Completed	No Results Available	Malaria, Falciparum|G6PD Deficiency	Drug: Dihydroartemisinin piperaquine (DHA PP)|Drug: Primaquine	Ratanakiri Provincial Hospital, Ratanakiri, Cambodia	https://ClinicalTrials.gov/show/NCT02434952
137	A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects	Completed	No Results Available	Falciparum Malaria	Drug: Amodiaquine (Test)|Drug: Amodiaquine (Comparator)	Pfizer Investigational Site, Singapore, Singapore	https://ClinicalTrials.gov/show/NCT00894660
138	Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects	Completed	No Results Available	Falciparum Malaria	Drug: Artesunate (Test)|Drug: Artesunate (Comparator)	Pfizer Investigational Site, Singapore, Singapore	https://ClinicalTrials.gov/show/NCT00894374
139	A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects	Completed	No Results Available	Falciparum Malaria	Drug: Flavoquine®, Camoquin® Suspension	Pfizer Investigational Site, Navi Mumbai, Maharashtra, India	https://ClinicalTrials.gov/show/NCT00859807
140	Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)	Active, not recruiting	No Results Available	Malaria,Falciparum|Children, Only	Biological: RABIPUR®|Biological: RTS,S/AS01|Drug: SMC with SP+AQ|Drug: SMC placebo	Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Ouagadougou, Burkina Faso|Malaria Research & Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT03143218
141	Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar	Completed	No Results Available	Drug Resistance|Plasmodium Falciparum Malaria	Drug: First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)	Dr. Myat Phone Kyaw, Yangon, Myanmar	https://ClinicalTrials.gov/show/NCT02792816
142	Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection	Completed	Has Results	Malaria, Falciparum|Malaria, Vivax	Drug: OZ439		https://ClinicalTrials.gov/show/NCT01213966
143	Artemisinin Resistance in Cambodia II	Completed	No Results Available	Falciparum Malaria	Drug: Artesunate	Tasanh Health Center, Sam Lot District, Battambang, Cambodia	https://ClinicalTrials.gov/show/NCT00722150
144	Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections	Recruiting	No Results Available	Malaria Diagnosis|Malaria,Falciparum	Diagnostic Test: hsRDT	University Research Co., LLC (URC), Yangon, Myanmar	https://ClinicalTrials.gov/show/NCT03511443
145	Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults	Completed	No Results Available	Malaria|Malaria,Falciparum	Biological: PfSPZ Vaccine|Other: Normal Saline Placebo|Biological: PfSPZ Challenge	Bagamoyo Research and Training Center of the Ifakara Health Institute, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT03420053
146	Phase II Dose Ranging Study of Artesunate	Completed	No Results Available	Falciparum Malaria|Uncomplicated Malaria	Drug: Artesunate for Injection	New Nyanza Provincial Hospital, Kisumu, Nyanza, Kenya|Kwai River Christian Hospital, Sangkhlaburi, Kanchanaburi, Thailand	https://ClinicalTrials.gov/show/NCT00459615
147	Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia	Completed	No Results Available	Malaria,Falciparum|Malaria|Antimalarials	Drug: Artesunate	Hospital Ismael Roldan and Centro de Salud San Vicente, Quibdo, Choco, Colombia	https://ClinicalTrials.gov/show/NCT00378625
148	A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan	Completed	No Results Available	Uncomplicated Falciparum Malaria|Vivax Malaria	Drug: Dihydroartemisinin + Piperaquine (Artekin)|Drug: artesunate-sulphadoxin/pyrimethamine, chloroquine	Provincial Malaria Control Centers (MRC), Faryab, Afghanistan|Provincial Malaria Control Centers (MRC), Jalalabad, Afghanistan|Provincial Malaria Control Centers (MRC), Maimana, Afghanistan|Provincial Malaria Control Centers (MRC), Takhar, Afghanistan	https://ClinicalTrials.gov/show/NCT00682578
149	Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia	Completed	No Results Available	Falciparum Malaria	Drug: Artesunate|Drug: Artesunate + Mefloquine	Pailin Referal Hospital, Pailin, Cambodia	https://ClinicalTrials.gov/show/NCT00493363
150	Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa	Completed	No Results Available	Drug Resistant Malaria Due to Plasmodium Falciparum	Drug: Arthemeter-lumefantrine|Drug: Artesunate mefloquine|Drug: Dihydroartemisinin piperaquine|Drug: Paracetamol|Drug: Amoxicillin|Drug: Quinine	CDC Hospital, Tiko, South west, Cameroon	https://ClinicalTrials.gov/show/NCT02974348
151	CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi	Completed	No Results Available	Malaria|Plasmodium Falciparum Malaria	Drug: chloroquine sulfate|Drug: sulfadoxine/pyrimethamine	Blantyre Malaria Project, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT00125489
152	Sporozoite Challenge of Polyprotein Vaccinees	Completed	No Results Available	Malaria, Falciparum|Malaria	Biological: FP9-PP (FP9 polyprotein)|Biological: MVA-PP (Modified Virus Ankara polyprotein)	Imperial College, University of London, London, United Kingdom|Centre for Clinical Vaccinology & Tropical Medicine, University of Oxford, Oxford, United Kingdom	https://ClinicalTrials.gov/show/NCT00375128
153	Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP	Completed	No Results Available	Malaria, Falciparum|Malaria	Biological: FP9-PP (FP9 polyprotein)|Biological: MVA-PP (Modified Virus Ankara polyprotein)	Centre for Clinical Vaccinology & Tropical Medicine, University of Oxford, Oxford, United Kingdom	https://ClinicalTrials.gov/show/NCT00374998
154	Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites	Recruiting	No Results Available	Plasmodium Falciparum Malaria (Drug Resistant)	Drug: Imatinib|Drug: Dihydroartemisinin-piperaquine	A Tuc, Hương Hóa, Quang Tri, Vietnam	https://ClinicalTrials.gov/show/NCT03697668
155	Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi	Completed	No Results Available	Malaria, Falciparum|HIV Infections	Drug: Monthly sulfadoxine/pyrimethamine|Drug: 2-dose sulfadoxine/pyrimethamine	Machinga District Hospital, Liwonde, Malawi	https://ClinicalTrials.gov/show/NCT00126906
156	Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen	Completed	No Results Available	Malaria|Malaria, Falciparum	Biological: PEV3A|Biological: FP9 ME-TRAP|Biological: MVA ME-TRAP	Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom	https://ClinicalTrials.gov/show/NCT00408668
157	Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa	Terminated	Has Results	Intermittent Preventive Treatment In Pregnancy (IPTp)	Drug: Azithromycin plus chloroquine|Drug: sulfadoxine-pyrimethamine	Centre de Santé d'AHOUANSORI-AGUE, Cotonou, Benin|Hôpital Bethesda, Cotonou, Benin|Siaya District Hospital, Siaya, Kenya|Zomba Central Hospital, Zomba, Malawi|Teule Hospital, Muheza, Tanga, Tanzania|Bugando Medical Centre, Mwanza, Tanzania|Nyamagana District Hospital, c/o National Institute for Medical Research, Mwanza Centre, Mwanza, Tanzania|Nyamagana District Hospital, Mwanza, Tanzania|Mulago Hospital Complex, Kampala, Uganda	https://ClinicalTrials.gov/show/NCT01103063
158	Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania	Completed	No Results Available	Falciparum Malaria	Biological: PEV 301& 302 in virosomes|Biological: Inflexal V (active comparator)	Bagamoyo Research and Training Unit, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT00513669
159	Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children	Completed	No Results Available	P. Falciparum Malaria	Drug: artemether-lumefantrine|Drug: Dihydroartemisinin-piperaquine	Miono Health Center, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT01082705
160	Study to Investigate the Induction of an Protective Immune Response to Malaria	Completed	No Results Available	Falciparum Malaria	Procedure: exposure to malaria sporozoites	Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands	https://ClinicalTrials.gov/show/NCT00442377
161	SJ733 Induced Blood Stage Malaria Challenge Study	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: (+)-SJ000557733	Q-Pharm Clinics, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia|Q-Pharm Clinics, Herston, Queensland, Australia	https://ClinicalTrials.gov/show/NCT02867059
162	Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides	Terminated	No Results Available	Falciparum Malaria	Biological: Virosome-formulated synthetic peptides (malaria vaccine)		https://ClinicalTrials.gov/show/NCT00400101
163	Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos	Terminated	No Results Available	Plasmodium Falciparum Malaria	Drug: KAE609|Drug: Piperaquine Phosphate	Novartis Investigative Site, Brisbane, Queensland, Australia	https://ClinicalTrials.gov/show/NCT02543086
164	Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru	Completed	No Results Available	Malaria Falciparum	Drug: mefloquine plus artesunate	Loreto Healthcare Facility, Iquitos, Loreto, Peru	https://ClinicalTrials.gov/show/NCT00164216
165	A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)|Biological: RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01)|Biological: ChAd63 ME-TRAP (5 x 10^10 vp)|Biological: MVA ME-TRAP (2 x 10^8 pfu)	NIHR WTCRF, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom|Surrey Clinical Research Centre, University of Surrey, Guildford, Surrey, United Kingdom|NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom	https://ClinicalTrials.gov/show/NCT02252640
166	Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children	Completed	Has Results	Plasmodium Falciparum Malaria	Biological: FMP1/AS02A Malaria vaccine|Biological: Imovax Rabies vaccine	Walter Reed Project Kombewa Clinic, Kombewa, Nyanza Province, Kenya	https://ClinicalTrials.gov/show/NCT00317473
167	Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America	Completed	Has Results	Plasmodium Falciparum Malaria	Biological: Falciparum Malaria Protein 11 with AS01B adjuvant.	Walter Reed Army Institute of Research, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT00312663
168	A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: RTS,S/AS01B|Biological: ChAd63 ME-TRAP|Biological: MVA ME-TRAP	Wellcome Trust CRF, Southampton General Hospital, University of Southampton, Southampton, Hampshire, United Kingdom|Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom|Infection and Immunity Section, Sir Alexander Fleming Building, Imperial College of Science, Technology and Medicine, London, United Kingdom|Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom	https://ClinicalTrials.gov/show/NCT01883609
169	Targeted Chemo-elimination (TCE) of Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: malaria elimination using DP and low-dose primaquine	Pailin, Pailin, Cambodia|Savannakhet, Savannakhet, Lao People's Democratic Republic|Mahidol Oxford Clincal Research Unit, Myanmar, Rangoon, Myanmar|Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand|Oxford University Clinical Research Unit - Vietnam, Ho Chi Minh city, Vietnam	https://ClinicalTrials.gov/show/NCT01872702
170	Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections	Completed	No Results Available	Plasmodium Falciparum Malaria	Device: HRP2 and LDH based rapid diagnostic tests for P.falciparum	Mlandizi Health Centre and Fukayosi dispencary, Dar es Salaam, Kibaha and Bagamoyo district, Tanzania|Muhimbili University of Health Allied Science, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT01843764
171	A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: ChAd63 CS/ME-TRAP|Biological: MVA CS/ME-TRAP|Biological: ChAd63 CS/ME-TRAP/AMA1|Biological: MVA CS/ME-TRAP/AMA1|Other: Controlled Human Malaria Infection Administered by Mosquito Bite	Wellcome Trust CRF, Southampton General Hospital, Southampton, Hampshire, United Kingdom|Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom|Infection and Immunity Section, Imperial College of Science, Technology and Medicine, London, United Kingdom	https://ClinicalTrials.gov/show/NCT01739036
172	A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: ChAd63-MVA CS|Biological: ChAd63-MVA ME-TRAP|Other: Controlled Human Malaria Infection Administered by Mosquito Bite	Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom|Infection and Immunity Section, Imperial College of Science, Technology and Medicine, London, United Kingdom|Wellcome Trust CRF, Southampton General Hospital, Southampton, United Kingdom	https://ClinicalTrials.gov/show/NCT01623557
173	Experimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Chloroquine prophylaxis|Biological: Immunization|Biological: Plasmodium falciparum Bloodstage challenge|Biological: Plasmodium falciparum mosquito challenge|Drug: Malarone treatment	Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands	https://ClinicalTrials.gov/show/NCT01236612
174	Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Chloroquine prophylaxis|Biological: Immunization|Biological: Plasmodium falciparum challenge|Drug: Malarone treatment	Leiden University Medical Centre, Leiden, Netherlands	https://ClinicalTrials.gov/show/NCT01218893
175	EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults	Completed	No Results Available	Plasmodium Falciparum Malaria	Drug: Placebo|Biological: EBA-175 RII-NG Malaria Vaccine	Noguchi Memorial Institute for Medical Research - Immunology, Legon, Greater Accra, Ghana	https://ClinicalTrials.gov/show/NCT01026246
176	Extended Duration Artemether-lumefantrine Treatment for Malaria in Children	Recruiting	No Results Available	Uncomplicated Plasmodium Falciparum Malaria	Drug: Artemether-lumefantrine	MGH campus, Busia, Uganda|IDRC- Tororo Research Clinic and Tororo District Hospital, Tororo, Uganda	https://ClinicalTrials.gov/show/NCT03453840
177	A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.	Completed	No Results Available	Malaria, Falciparum|Malaria, Vivax	Drug: Amodiaquine plus artesunate; Artekin	SP9 & SP12 Public Health & Malaria Control Clinics, Timika, Papua, Indonesia	https://ClinicalTrials.gov/show/NCT00157885
178	The Community Effectiveness of IPTi in Southern Tanzania	Unknown status	No Results Available	Malaria, Falciparum|Anemia	Drug: Sulfadoxine-pyrimethamine used for IPTi|Drug: IPTi	Ifakara Health Research & Development Centre, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT00152204
179	Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers	Completed	No Results Available	Plasmodium Falciparum Malaria	Biological: PfAMA-1-FVO[25-545]	Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands|Biomedical Primate Research Centre, Rijswijk, Netherlands	https://ClinicalTrials.gov/show/NCT00730782
180	Malarial Immunity in Pregnant Cameroonian Women	Unknown status	No Results Available	Plasmodium Falciparum Malaria		University of Yaounde 1, Yaounde, Cameroon	https://ClinicalTrials.gov/show/NCT00593398
181	Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali	Completed	Has Results	Plasmodium Falciparum Malaria	Biological: FMP2.1/AS02A|Biological: Rabies Vaccine	University of Bamako, Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00460525
182	Malaria Transmission and Immunity in Highland Kenya	Completed	No Results Available	Plasmodium Falciparum Malaria		Kenya Medical Research Institute, Kisumu, Kenya	https://ClinicalTrials.gov/show/NCT00393757
183	CS DNA MVA Trial in Mampong, Ghana	Withdrawn	No Results Available	Plasmodium Falciparum Malaria	Biological: MVA-CSO Vaccine|Biological: PfCSP DNA (VCL-2510) Vaccine	Naval Medical Research Center, Silver Spring, Maryland, United States|Noguchi Memorial Institute of Medical Research, Legon, Ghana	https://ClinicalTrials.gov/show/NCT00377494
184	Phase I Pediatric FMP2.1/AS02A Trial in Mali	Completed	Has Results	Plasmodium Falciparum Malaria	Biological: FMP2.1/AS02A|Biological: Rabies vaccine (RabAvert)	University of Bamako, Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00358332
185	Malaria Prevalence in Children	Completed	No Results Available	Plasmodium Falciparum Malaria		Medical Research Council's Laboratories, Fajara, Gambia	https://ClinicalTrials.gov/show/NCT00322816
186	Time to Infection With Malaria Parasites	Completed	No Results Available	Plasmodium Falciparum Malaria		Medical Research Council's Laboratories, Fajara, Gambia	https://ClinicalTrials.gov/show/NCT00322738
187	Human Immunity to MSP-1 in Western Kenya	Unknown status	No Results Available	Plasmodium Falciparum Malaria		Kenya Medical Research Institute, Kisumu, Kenya	https://ClinicalTrials.gov/show/NCT00138372
188	Pentoxifylline in Children With Malaria	Terminated	No Results Available	Plasmodium Falciparum Malaria	Drug: Pentoxifylline	KEMRI Centre for Geographic Medicine Research, Kilifi, Kenya	https://ClinicalTrials.gov/show/NCT00133393
189	Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010	Withdrawn	No Results Available	Malaria, Falciparum|Malnutrition|Child	Drug: Artesunate-amodiaquine fixed-dose combination	Integrated health centre (CSI), Madaoua, Tahoua, Niger	https://ClinicalTrials.gov/show/NCT01204411
190	FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali	Completed	Has Results	Malaria|Plasmodium Falciparum Malaria	Biological: FMP2.1/AS02A|Biological: Rabies vaccine (RabAvert)	University of Bamako, Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00349713
191	Re-exposure of EHMI-8 Human Volunteers to Live Malaria Sporozoites	Completed	No Results Available	P. Falciparum Malaria	Biological: Exposure to 5 P. falciparum infected mosquitoes	UMC St. Radboud, Nijmegen, Netherlands	https://ClinicalTrials.gov/show/NCT00757887
192	A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults	Not yet recruiting	No Results Available	Vaccine Reaction	Drug: FMP013|Drug: ALFQ	WRAIR, Clinical Trials Center, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT04268420
193	Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil	Completed	Has Results	Malaria	Drug: Artemether-lumefantrine combination	Hospital do Jurua, Cruzeiro do Sul, Brazil	https://ClinicalTrials.gov/show/NCT02600767
194	Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity	Suspended	No Results Available	Uncomplicated Plasmodium Falciparum Malaria	Drug: DHA-piperaquine and Primaquine	Anlong Veng Referral Hospital, Anlong Veng, Oddormean Chey, Cambodia	https://ClinicalTrials.gov/show/NCT01849640
195	MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria	Suspended	No Results Available	Malaria	Drug: MMV390048	University of Gondar Hospital/Maksegnit Health Centre, Gondar, Amhara, Ethiopia|Jimma University Referral Hospital/Agaro District Hospital, Jimma, Oromia, Ethiopia	https://ClinicalTrials.gov/show/NCT02880241
196	The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance	Completed	No Results Available	Falciparum Malaria|Antimalarials		Tropical Medicine Research Institute, Khartoum, Sudan	https://ClinicalTrials.gov/show/NCT00440752
197	Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines	Completed	No Results Available	Malaria	Drug: artemether/lumafantrine vs chloroquine/sulfadoxine-pyrimethamine	Kalinga Health Center, Tabuk, Kalinga Province, Philippines|Davao Health Center, Davao City, Mindinao, Philippines|Palawan Health Center, Puerto Princesa, Palawan, Philippines	https://ClinicalTrials.gov/show/NCT00229775
198	Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria	Completed	No Results Available	Plasmodium Falciparum Infection	Drug: Artefenomel OZ439|Drug: Ferroquine SSR97193	Investigational Site Number 2040001, Cotonou, Benin|Investigational Site Number 8540001, Ouagadougou, Burkina Faso|Investigational Site Number 8540002, Ouagadougou, Burkina Faso|Investigational Site Number 2660002, Lambarene, Gabon|Investigational Site Number 2660001, Libreville, Gabon|Investigational Site Number 4040002, Siaya County, Kenya|Investigational Site Number 8000001, Tororo, Uganda	https://ClinicalTrials.gov/show/NCT03660839
199	A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5	Completed	No Results Available	Malaria|Plasmodium Falciparum	Biological: ChAd63 RH5 low dose|Biological: ChAd63 RH5 full dose|Biological: MVA RH5 low dose|Biological: MVA RH5 full dose	Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom|Wellcome Trust CRF, Southampton General Hospital, University of Southampton, Southampton, United Kingdom	https://ClinicalTrials.gov/show/NCT02181088
200	Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger	Completed	No Results Available	Malaria	Drug: Artesunate-amodiaquine|Drug: Dihydroartemisinin-piperaquine|Drug: Artemether-lumefantrine	Andoumé Health Centre, Maradi, Niger	https://ClinicalTrials.gov/show/NCT01755559
201	Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults	Completed	No Results Available	Malaria	Biological: Group 1: 10 ug FMP012 with 2 ug GLA-SE|Biological: Group 2: 10 ug FMP012 with 5 ug GLA-SE|Biological: 50 ug FMP012 with 5 ug GLA-SE or 2 ug GLA-SE	Clinical Trials Center, WRAIR, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT01540474
202	Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali	Completed	No Results Available	Malaria		University of Bamako, Faculty of Medicine, Pharmacy and Odontostomatology, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00669084
203	Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children	Completed	No Results Available	Malaria	Drug: Fosmidomycin and Clindamycin co-administration	Centro de Investigacao em Saude da Manhica, Maputo, Mozambique	https://ClinicalTrials.gov/show/NCT01464138
204	To Evaluate the Efficacy of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria	Terminated	No Results Available	Plasmodium Falciparum Infection	Drug: Ferroquine SSR97193|Drug: Artefenomel|Other: Placebo	Investigational Site Number 204001, Cotonou, Benin|Investigational Site Number 854001, Nanoro, Burkina Faso|Investigational Site Number 854003, Niangoloko, Burkina Faso|Investigational Site Number 854002, Ouagadougou, Burkina Faso|Investigational Site Number 266001, Dalian, Gabon|Investigational Site Number 266002, Lambaréné, Gabon|Investigational Site Number 404002, Kisian, Kenya|Investigational Site Number 404003, Kisumu, Kenya|Investigational Site Number 508001, Chengdu, Mozambique|Investigational Site Number 800002, Tororo, Uganda|Investigational Site Number 704003, Binh Phuoc, Vietnam|Investigational Site Number 704004, Gia Lai, Vietnam|Investigational Site Number 704001, Khanh Hoa, Vietnam|Investigational Site Number 704002, Quang Tri, Vietnam	https://ClinicalTrials.gov/show/NCT02497612
205	Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults	Unknown status	No Results Available	Malaria	Drug: Fosmidomycin|Drug: Azithromycin	Mahidol University, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT01464125
206	Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali	Completed	No Results Available	Malaria	Biological: Pfs230D1M-EPA/Alhydrogel|Biological: Pfs25M-EPA/Alhydrogel|Drug: TWINRIX|Drug: Menactra	National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT02334462
207	Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria	Unknown status	No Results Available	Malaria	Drug: Fosmidomycin and clindamycin	Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon	https://ClinicalTrials.gov/show/NCT01361269
208	Controlled Double Blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B	Completed	No Results Available	Malaria	Biological: Plasmodium falciparum Malaria Protein 010 (FMP010)|Biological: Rabipur		https://ClinicalTrials.gov/show/NCT02458092
209	Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers	Completed	No Results Available	Uncomplicated Plasmodium Falciparum Malaria	Device: Rapid diagnostic test for malaria	Villages, Kibaha, Kibaha District, Tanzania	https://ClinicalTrials.gov/show/NCT00301015
210	A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria	Completed	No Results Available	Malaria	Biological: AMA1-C1/Alhydrogel® + CPG 7909	Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Headington, United Kingdom	https://ClinicalTrials.gov/show/NCT00984763
211	Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period	Unknown status	No Results Available	Malaria	Drug: Artemether-lumefantrine combination	Malawi-Liverpool-Wellcome Trust Research Programme, College of Medicine, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT01038063
212	Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum	Completed	No Results Available	Asymptomatic P.Falciparum Malaria	Drug: Sulfadoxine-pyrimethamine|Drug: Sulfadoxine-pyrimethamine plus artesunate	Medical Reseearch Council Laboratories The Gambia, Banjul, Gambia	https://ClinicalTrials.gov/show/NCT00289250
213	Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso	Completed	No Results Available	Malaria	Drug: Amodiaquine	Centre de Recherche en Santé de Nouna (CRSN), Nouna, Burkina Faso	https://ClinicalTrials.gov/show/NCT00261222
214	Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali	Completed	No Results Available	Malaria	Drug: BSAM2/Alhydrogel + CPG 7909	Johns Hopkins University, Baltimore, Maryland, United States|Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00889616
215	Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria	Completed	No Results Available	Malaria	Drug: Artesunate-Mefloquine	Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon|Département de Parasitologie-Mycologie, Faculte de medecine, Libreville, Gabon	https://ClinicalTrials.gov/show/NCT00243737
216	Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria	Completed	No Results Available	Malaria	Drug: Administration of quinine sulphate taste-masked pellets	Centre Hospitalier De Butare, Butare, Rwanda	https://ClinicalTrials.gov/show/NCT00329134
217	Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria	Completed	No Results Available	Malaria	Drug: AQAS	Bondo District Hospital, Kisumu, Kenya	https://ClinicalTrials.gov/show/NCT00425763
218	Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.	Completed	No Results Available	Malaria	Drug: Azithromycin plus Chloroquine|Drug: Mefloquine	Pfizer Investigational Site, Ouagadougou, West Africa, Burkina Faso|Pfizer Investigational Site, Nouna, Burkina Faso|Pfizer Investigational Site, Navrongo, West Africa, Ghana|Pfizer Investigational Site, Kisumu, Kenya|Pfizer Investigational Site, Bamako, West Africa, Mali|Pfizer Investigational Site, Bamako, Mali|Pfizer Investigational Site, Senegal, West Africa, Senegal|Pfizer Investigational Site, Ndola, Zambia	https://ClinicalTrials.gov/show/NCT00367653
219	Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children	Completed	No Results Available	Malaria	Drug: Chlorproguanil-dapsone + artesunate	Programme Nationale Integre de Lutte contre le Paludisme, Kigali, Rwanda	https://ClinicalTrials.gov/show/NCT00461578
220	Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients	Completed	No Results Available	Malaria	Drug: pyronaridine artesunate|Drug: arthemeter lumefantrine	Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso|Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa, DRC, Congo|Unité de Paludologie de l'Institut Pasteur d'Abidjan, Abdijan, Côte D'Ivoire|Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon|Siaya District Hospital, Medical Superintendent's office, Siaya Town, Kenya|Malaria Research and Training Center, Faculté de Médecine, de Pharmacie et d'Ondonto-stomatologie, Bamako, Mali|Instituto Nacional de Saude, Ministero de Saude, Maputo, Mozambique|Puerto Princesa General Hospital, Puerto Princesa, Philippines	https://ClinicalTrials.gov/show/NCT00541385
221	Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients	Completed	No Results Available	Malaria	Drug: Pyronaridine artesunate|Drug: Coartem® (artemether lumefantrine)	Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa, DRC, Congo|Farafenni Field Station, c/o: MRC Laboratories, Fajara, Gambia|Komfo Anoykye Teaching Hospital, Kumasi, Ghana|RSUD TC Hillers, Maumere, Nusa Tenggara Timur, Indonesia|Jayapura General Hospital (RSUD) DOK II, Jayapura, Papua, Indonesia|Siaya District Hospital, Medical Superintendent's office, Siaya Town, Kenya|Malaria Research and Training Center, Faculté de Médecine, de Pharmacie et d'Ondonto-stomatologie, Bamako, Mali|Instituto Nacional de Saude, Ministero de Saude, Maputo, Mozambique|Puerto Princesa General Hospital, Puerto Princesa, Philippines|Service de Parasitologie, Faculté de Médecine, Université Cheikh Anta Diop, Dakar, Dakar Fann, Senegal	https://ClinicalTrials.gov/show/NCT00422084
222	Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks	Completed	No Results Available	Malaria	Drug: Coarsucam® (artésunate (AS) + amodiaquine (AQ) as fixed dose combination)|Drug: Coartem® (arthemether+ lumefantrine)	Sanofi-Aventis Administrative Office, Dakar, Senegal	https://ClinicalTrials.gov/show/NCT00540410
223	TES Artemether-lumefantrine for Pf and Chloroquine (CQ) for Pv	Completed	No Results Available	Malaria|Falciparum Malaria|Vivax Malaria	Drug: Arthemeter-lumefantrine|Drug: Chloroquine		https://ClinicalTrials.gov/show/NCT04222088
224	Pyronaridine Artesunate (3:1) Versus Mefloquine Artesunate in P Falciparum Malaria Patients	Completed	No Results Available	Malaria	Drug: Pyronaridine artesunate|Drug: Mefloquine plus artesunate	RAOTAP2/Centre Muraz, Bobo Dioulasso, Houet Province, Burkina Faso|Pailin Referral Hospital, Pailin, Pailin Province, Cambodia|Institut Pasteur, Abidjan, Côte D'Ivoire|Wentlock District Hospital, Mangalore, India|Bagamoyo Research and Training Centre of Ifakara Health Institute, Bagamoyo, Tanzania|MaeLamad District Hospital, MaeLamad, Tak Province, Thailand|MaeSod General Hospital, MaeSod, Tak Province, Thailand|NIMPE, Hanoi, Commune Xy, Vietnam|Choray Hospital, Dak O, Ho Chi Minh City, Vietnam	https://ClinicalTrials.gov/show/NCT00403260
225	A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate	Completed	No Results Available	Prophylaxis Against Plasmodium Falciparum Malaria	Biological: Plasmodium falciparum Chimeric Prot. 2.9 - Montanide ISA 720	Shanghai Changhai Hospital, Shanghai, China	https://ClinicalTrials.gov/show/NCT00284973
226	Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks	Completed	No Results Available	Malaria	Drug: Coarsucam|Drug: Coartem	Sanofi-aventis administrative office, Kampala, Uganda	https://ClinicalTrials.gov/show/NCT00699920
227	Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.	Completed	No Results Available	Malaria|Falciparum	Drug: Artemether-lumefantrine	Novartis, Benin, Benin|Novartis, Kenya, Kenya|Novartis, Mali, Mali|Novartis, Mozambique, Mozambique|Novartis, Tanzania, Tanzania	https://ClinicalTrials.gov/show/NCT00386763
228	Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers	Completed	No Results Available	Acute Uncomplicated P. Falciparum Malaria	Drug: Co-artemether		https://ClinicalTrials.gov/show/NCT00233337
229	Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers	Completed	No Results Available	P. Falciparum Malaria|P. Falciparum Malaria Mixed Infection		Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand	https://ClinicalTrials.gov/show/NCT02427360
230	ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria	Completed	No Results Available	Malaria	Drug: Artesunate + Amodiaquine	CHU, Yaounde, Cameroon|Centre de santé, Tsiroanomandidy, Madagascar|Bancoumana, Mali|Keur Socé, Senegal|Oussouye, Senegal	https://ClinicalTrials.gov/show/NCT00316329
231	Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults	Completed	No Results Available	Malaria|Plasmodium Falciparum Malaria	Biological: PfSPZ Vaccine|Biological: Normal Saline (Placebo)|Biological: PfSPZ Challenge	Bagamoyo Research and Training Center, Ifakara Health Institute, Kingani Estate, PO Box 74, Bagamoyo, Tanzania	https://ClinicalTrials.gov/show/NCT02132299
232	Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis	Completed	No Results Available	Malaria|Plasmodium Falciparum Malaria	Biological: PfSPZ Challenge|Biological: 0.9% Sodium Chloride (Placebo)	Institute of Tropical Medicine, University of Tuebingen, Wilhelmstr. 27, Tübingen, Germany	https://ClinicalTrials.gov/show/NCT02115516
233	Additional Screening With Sensitives RDTs and Malaria	Not yet recruiting	No Results Available	Plasmodium Falciparum Malaria|Malaria Diagnosis	Diagnostic Test: Additional screening using ultra sensitive RDTs|Drug: Dihydroartemisinin-piperaquin|Other: Reminders	Institut de Recherche en Sciences de la Santé/ Clinical Research Unit of Nanoro, Ouagadougou, Kadiogo, Burkina Faso	https://ClinicalTrials.gov/show/NCT04147546
234	Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America	Completed	Has Results	Malaria|Plasmodium Falciparum Malaria	Biological: Falciparum Malaria Protein 11 with AS02A adjuvant	Walter Reed Army Institute of Research, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT00312702
235	Hyperphenylalaninemia in Cerebral Malaria	Completed	No Results Available	Plasmodium Falciparum Malaria		Hubert Kairuki Memorial University, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT00338520
236	Plasmodium Resistance in A. Gambiae	Completed	No Results Available	Malaria|Plasmodium Falciparum Malaria		Centre National de Recherche et de Formation sur le Paludisme, West Africa, Burkina Faso	https://ClinicalTrials.gov/show/NCT00466557
237	Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria	Not yet recruiting	No Results Available	Human African Trypanosomiasis	Diagnostic Test: No intervention		https://ClinicalTrials.gov/show/NCT03394976
238	Short Course Radical Cure of P. Vivax Malaria in Nepal	Not yet recruiting	No Results Available	Malaria|Malaria, Vivax|Malaria,Falciparum	Drug: primaquine		https://ClinicalTrials.gov/show/NCT04079621
239	To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia	Completed	No Results Available	Falciparum Malaria|Vivax Malaria	Drug: Chloroquine and sulphadoxine-pyrimethamine	SP9 & SP12 Public Health- Malaria control clinics, Timika, Papua, Indonesia	https://ClinicalTrials.gov/show/NCT00157859
240	A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.	Completed	No Results Available	Falciparum Malaria|Vivax Malaria	Drug: Artekin / Coartemther	SP9 and SP12 Malaria-Public Health Clinics, Timika, Papua, Indonesia	https://ClinicalTrials.gov/show/NCT00157833
241	DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax	Completed	No Results Available	Plasmodium Falciparum Malaria|Plasmodium Vivax Malaria	Drug: DSM265 400mg|Drug: DSM265 xmg|Drug: DSM265 ymg	Clínica de la Asociación Civil Selva Amazónica, Iquitos, Departamento de Loreto (Amazonía Peruana), Peru	https://ClinicalTrials.gov/show/NCT02123290
242	Malaria in Early Life Study	Completed	No Results Available	Plasmodium Falciparum Malaria|Plasmodium Vivax Malaria	Drug: dihydroartemisinin-piperaquine	Timika Research Facility, Timika, Papua, Indonesia	https://ClinicalTrials.gov/show/NCT02001428
243	Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge	Completed	No Results Available	Plasmodium Falciparum Malaria|Malaria	Biological: PfSPZ Challenge	Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon	https://ClinicalTrials.gov/show/NCT02237586
244	Malaria Vaccine Evaluation Programme	Active, not recruiting	No Results Available	Malaria,Falciparum|Feasibility|Safety|Mortality	Biological: RTS,S/AS01E	Kintampo Health Research Centre, Kintampo, Ghana|CDC Kenya Malaria Programme, Kisumu, Kenya|College of Medicine, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT03806465
245	Safety and Efficacy of NF135 CPS Immunization	Recruiting	No Results Available	Malaria,Falciparum|Controlled Human Malaria Infection|Immunization; Infection	Biological: CPS-immunization|Biological: malaria challenge infection, P. falciparum NF135.C10|Biological: malaria challenge infection, P. falciparum NF54|Biological: malaria challenge infection, P. falciparum NF166.C8|Drug: Atovaquone / Proguanil Oral Tablet [Malarone]	Radboud university medical centre, Nijmegen, Gelderland, Netherlands	https://ClinicalTrials.gov/show/NCT03813108
246	Safety and Protective Efficacy of Pb(PfCS@UIS4)	Completed	No Results Available	Malaria,Falciparum|Plasmodium Falciparum|Plasmodium Berghei|Controlled Human Malaria Infection (CHMI)	Biological: Pb(PfCS@UIS4)-infected mosquitoes|Other: Challenge infection P. falciparum	Havenziekenhuis, Rotterdam, Netherlands	https://ClinicalTrials.gov/show/NCT03138096
247	Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea	Not yet recruiting	No Results Available	Plasmodium Falciparum Malaria|Pregnancy Malaria|Diagnoses Disease	Diagnostic Test: HS-RDT		https://ClinicalTrials.gov/show/NCT03462615
248	A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects	Completed	Has Results	Malaria Falciparum|Malaria Vivax|Healthy Volunteers	Drug: OZ439 50mg API capsules|Drug: OZ439 200mg API capsules|Drug: OZ439 400mg aqueous dispersion|Drug: OZ439 800mg aqueous dispersion|Drug: OZ439 100mg API capsules|Drug: OZ439 400mg API capsules|Drug: OZ439 1600mg aqueous dispersion|Drug: OZ439 800mg API capsules|Drug: OZ439 1200mg API capsules|Drug: Placebo|Drug: OZ439 200mg aqueous dispersion	Comprehensive Phase One Miramar; 3400 Enterprise Way, Miramar, Florida, United States	https://ClinicalTrials.gov/show/NCT00928083
249	Non-specific Effects of Vaccination on Mortality and Morbidity	Active, not recruiting	No Results Available	Vaccine Reaction|Anemia|Malaria,Falciparum|Salmonella Bacteraemia	Other: Venipuncture	Clinical Research Unit of Nanoro, Nanoro, Boulkiemedé, Burkina Faso	https://ClinicalTrials.gov/show/NCT03176719
250	Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma	Completed	No Results Available	Malaria, Falciparum|Hookworm Infections|Schistosoma Haematobium	Dietary Supplement: Fe-57 orally, Fe-58 intravenously	Taabo Cité Hospital, Taabo, Côte D'Ivoire	https://ClinicalTrials.gov/show/NCT01163877
251	Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine	Withdrawn	No Results Available	Malaria|Malaria Vaccines|Plasmodium Falciparum Malaria	Biological: Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine		https://ClinicalTrials.gov/show/NCT00977899
252	Effect of Paracetamol on Kidney Function in Severe Malaria	Not yet recruiting	No Results Available	Severe Malaria|Malaria,Falciparum|Acute Kidney Injury|Paracetamol	Drug: Paracetamol|Procedure: Mechanical antipyresis	The Kinshasa Medical Oxford Research Unit (KIMORU), Kinshasa, Congo, Congo, The Democratic Republic of the	https://ClinicalTrials.gov/show/NCT04251351
253	Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on Weight	Completed	No Results Available	Weight Loss|Weight Gain|Convalescence|Malaria	Dietary Supplement: RUTF (Plumpynut®)	Central Hospital, Dubie, Katanga, Congo	https://ClinicalTrials.gov/show/NCT00819858
254	ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan	Completed	No Results Available	Malaria|Falciparum Malaria|Vivax Malaria	Drug: SP, chloroquine, amodiaquine, primaquine, artesunate	HealthNet International, Peshawar, Pakistan	https://ClinicalTrials.gov/show/NCT00158548
255	Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria	Terminated	No Results Available	Plasmodium Falciparum Infection	Drug: Ferroquine (SSR97193)|Drug: Placebo|Drug: artesunate	Sanofi-Aventis Investigational Site Number 204001, Cotonou, Benin|Sanofi-Aventis Investigational Site Number 854002, Bobo-Dioulasso 01, Burkina Faso|Sanofi-Aventis Investigational Site Number 854003, Nouna, Burkina Faso|Sanofi-Aventis Investigational Site Number 854001, Ouagadougou, Burkina Faso|Sanofi-Aventis Investigational Site Number 120001, Yaounde, Cameroon|Sanofi-Aventis Investigational Site Number 266001, B.P. 118 Lambarene, Gabon|Sanofi-Aventis Investigational Site Number 266002, Libreville, Gabon|Sanofi-Aventis Investigational Site Number 404001, Kilifi, Kenya|Sanofi-Aventis Investigational Site Number 404002, Kisumu, Kenya|Sanofi-Aventis Investigational Site Number 834001, Korogwe, Tanzania	https://ClinicalTrials.gov/show/NCT00988507
256	Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2	Completed	No Results Available	Malaria,Falciparum|Gametocytes|Controlled Human Malaria Infection|Transmission	Drug: Piperaquine (low dose)|Drug: Piperaquine (high dose)|Drug: Sulfadoxine pyrimethamine|Drug: Atovaquone Proguanil|Other: malaria challenge infection, P. falciparum 3D7|Other: Blood stage malaria challenge infection, P. falciparum 3D7	Radboud university medical center, Nijmegen, Gelderland, Netherlands	https://ClinicalTrials.gov/show/NCT03454048
257	Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo	Not yet recruiting	No Results Available	Bloodstream Infection|Health Care Utilization|Malaria,Falciparum|Salmonella Infection Non-Typhoid|Febrile Illness			https://ClinicalTrials.gov/show/NCT04289688
258	Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria	Completed	No Results Available	Malaria	Drug: Paracetamol|Drug: No Paracetamol	Chittagong Medical College Hospital, Chittagong, Bangladesh|Ramu Upazilla Health Complex, Ramu, Bangladesh	https://ClinicalTrials.gov/show/NCT01641289
259	DSM265 Prophylaxis of Plasmodium Falciparum Malaria	Completed	No Results Available	Healthy	Drug: DSM265|Drug: Placebo|Biological: Sporozoites|Biological: Infective mosquito bite	Fred Hutchinson Cancer Research Center - Prevention Center, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT02562872
260	Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria	Completed	No Results Available	Malaria	Drug: Intrarectal artesunate|Drug: Intravenous artesunate|Drug: Intravenous quinine	Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the	https://ClinicalTrials.gov/show/NCT02492178
261	Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania	Completed	No Results Available	Uncomplicated Malaria	Drug: Artemether-Lumefantrine		https://ClinicalTrials.gov/show/NCT03387631
262	Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan	Unknown status	No Results Available	Malaria	Drug: Dihydroartemisinin- piperaquine|Drug: artemether- lumefantrine	Sinnar, Cinnar, Blue Nile, Sudan	https://ClinicalTrials.gov/show/NCT01075945
263	Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria	Completed	No Results Available	Malaria	Drug: Chlorproguanil-dapsone-artesunate (CDA)	GSK Investigational Site, Banjul, Gambia|GSK Investigational Site, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT00519467
264	Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria	Suspended	No Results Available	Malaria	Drug: chloroquine|Drug: dehydroepiandrosterone sulphate	Institute of Medical Research and study of Medicinal Plants, Medical Research Center, Yaounde, Cameroon	https://ClinicalTrials.gov/show/NCT00442403
265	Malaria Genetic Surveillance	Recruiting	No Results Available	Plasmodium Falciparum		National Centre for Malaria Control, Parasitology and Entomology (CNM), Phnom Penh, Cambodia|Center of Malariology, Parasitology and Entomology, Vientiane, Lao People's Democratic Republic|Buntharik hospital, Ubon Ratchathani, Thailand|Na Chaluai hospital, Ubon Ratchathani, Thailand|Institute of Malariology, Parasitology, and Entomology Quy Nhon, Qui Nhon, Vietnam	https://ClinicalTrials.gov/show/NCT03384498
266	Malaria Studies in Cambodia	Completed	No Results Available	Malaria		National Center for Parasitology, Entomology, and Malaria Controk, Ministry of H, Phnom Penh, Cambodia|Preah Vihear Referral Hospital, Preah Vihear Province, Cambodia|Ratanakiri Referral Hospital, Ratanakiri Province, Cambodia	https://ClinicalTrials.gov/show/NCT00663546
267	Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda	Suspended	No Results Available	Severe Malaria	Other: Blood sample (combined with malaria RDT) followed by gentoyping analysis	Health Zone of Kenge, Kenge, Kwango, Congo, The Democratic Republic of the|Health Zone of Ipamu, Ipamu, Kwilu, Congo, The Democratic Republic of the|Health Zone of Kingandu, Kingandu, Kwilu, Congo, The Democratic Republic of the|Adamawa State, selected LGAs, Yola, Adamawa, Nigeria|Apac District, Lira, Apac, Uganda|Kole District, Lira, Kole, Uganda|Oyam District, Lira, Oyam, Uganda	https://ClinicalTrials.gov/show/NCT04037332
268	Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria	Completed	No Results Available	Malaria	Drug: Pyronaridine-artesunate|Drug: Artemether-lumefantrine combination	St. Jude's Clinic, ICIPE, Mbita, Kenya	https://ClinicalTrials.gov/show/NCT02411994
269	Amodiaquine+Artesunate for Uncomplicated Malaria Treatment	Completed	No Results Available	Uncomplicated Malaria	Drug: Artesunate-Amodiaquine	CRUN, Nanoro, Boulkiemdé, Burkina Faso	https://ClinicalTrials.gov/show/NCT01213433
270	A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate	Completed	No Results Available	Malaria	Biological: RH5.1/ ASO1	Guys and St Thomas' NIHR CRF, London, United Kingdom|Nihr Wtcrf, Southampton, United Kingdom	https://ClinicalTrials.gov/show/NCT02927145
271	Single Low-dose Primaquine Efficacy and Safety.	Recruiting	No Results Available	Malaria	Drug: Primaquine	Tropical Pesticides Research Institute (TPRI), Arusha, Tanzania	https://ClinicalTrials.gov/show/NCT03352843
272	A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration	Recruiting	No Results Available	Malaria	Biological: ChAd63-METRAP|Biological: MVA ME-TRAP	Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom	https://ClinicalTrials.gov/show/NCT03084289
273	Harmonized AS/MQ Efficacy Study - Thailand	Completed	No Results Available	Malaria	Drug: Artesunate/mefloquine (AS/MQ)	Kwai River Christian Hospital in Sangklaburi, Amphoe Sangkhlaburi, Kanchanaburi, Thailand	https://ClinicalTrials.gov/show/NCT02052323
274	Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria	Completed	No Results Available	Anaemia	Drug: artesunate|Drug: quinine	Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the	https://ClinicalTrials.gov/show/NCT02092766
275	Plasmodium Falciparum Artemisinin Resistance Vietnam	Completed	No Results Available	Plasmodium Falciparum	Drug: Arterakin (DHA-PPQ)	Health Centre Tra Leng, Tra Leng, Quang Nam, Vietnam	https://ClinicalTrials.gov/show/NCT01775592
276	Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area	Completed	No Results Available	Malaria|Fever	Other: Rapid diagnostic test	HealthNet TPO, Jalalabad, Nangahar, Afghanistan|Merlin, Kunduz, Afghanistan	https://ClinicalTrials.gov/show/NCT00935688
277	VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection	Completed	No Results Available	Malaria	Biological: Blood-stage controlled human P. falciparum malaria infection	CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom	https://ClinicalTrials.gov/show/NCT03906474
278	Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso	Completed	No Results Available	Malaria	Drug: Amodiaquine-Artesunate|Drug: Artemether-lumefantrine	Clinical Reaserch Unit, Nanoro, Boulkiemdé, Burkina Faso	https://ClinicalTrials.gov/show/NCT01697787
279	Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria	Completed	Has Results	Malaria|Severe Malaria	Drug: Actidose Aqua|Drug: Artesunate|Drug: Amodiaquine	Universite des Sciencies, Techniques et Technologies de Bamako, Bamako, Mali	https://ClinicalTrials.gov/show/NCT01955382
280	A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313	Completed	No Results Available	Malaria	Biological: ChAd63 Pfs25-IMX313|Biological: MVA Pfs25-IMX313	CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|NIHR Wellcome Trust Clinical Research Facility, Southampton, United Kingdom	https://ClinicalTrials.gov/show/NCT02532049
281	The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia	Active, not recruiting	No Results Available	Malaria	Drug: atovaquone-proguanil|Drug: artesunate-atovaquone-proguanil	Anlong Veng Referral Hospital, Anlong Veng, Oddar Meancheay, Cambodia	https://ClinicalTrials.gov/show/NCT02297477
282	Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo	Completed	No Results Available	Malaria	Drug: Amodiaquine-Artesunate (ASAQ)|Drug: Artemether-Lumefantrine (AL)		https://ClinicalTrials.gov/show/NCT02741024
283	Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy	Completed	No Results Available	Malaria	Drug: 3-day artemether-lumefantrine|Drug: 5-day artemether-lumefantrine	University of Kinshasa, Democratic Republic of Congo, Kinshasa, Congo	https://ClinicalTrials.gov/show/NCT01916954
284	Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine	Completed	No Results Available	Malaria	Drug: Quinine plus sulfadoxine-pyrimethamine	Medical Research Unit, Lambaréné, Lambaréné, Moyen Ogooué, Gabon	https://ClinicalTrials.gov/show/NCT00167739
285	Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children	Completed	Has Results	Malaria	Biological: GSK Biological's Investigational Malaria Vaccine 257049|Biological: Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);|Biological: Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine (Rabipur or equivalent) (Novartis).	GSK Investigational Site, Kisian, Kenya|GSK Investigational Site, Kisumu, Kenya	https://ClinicalTrials.gov/show/NCT01148459
286	A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection	Completed	Has Results	Malaria	Drug: KAE609	Novartis Investigative Site, Ho Chi Minh, Vietnam	https://ClinicalTrials.gov/show/NCT01836458
287	Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate	Withdrawn	No Results Available	Malaria	Drug: Fosmidomycin	Mahidol University, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT01002183
288	In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children	Completed	No Results Available	Malaria	Drug: Coartem™ (Artemether-lumefantrine combination)|Drug: Coarsucam™ (Amodiaquine-artesunate combination)	Hospital Rural de Montepuez, Montepuez, Cabo Delgado, Mozambique|Hospital Rural de Chókwe,, Chokwe, Gaza, Mozambique|Centro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique|Centro de Saúde de Dondo, Dondo, Sofala, Mozambique|Hospital Provinvial de Tete, Tete, Mozambique	https://ClinicalTrials.gov/show/NCT02168569
289	Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo	Completed	No Results Available	Malaria	Drug: artesunate-amodiaquine|Drug: artemether-lumefantrine|Drug: Dihydroartemisinine-piperaquine	Centre de santé Bolenge, Bolenge, Equateur, Congo, The Democratic Republic of the|Centre de Santé Lupidi 1, Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the|Centre de Santé de Référence Mikalayi, Kazumba, Kasai Central, Congo, The Democratic Republic of the|Centre Evangélique de Coopération, Kimpese, Kongo Central, Congo, The Democratic Republic of the|Centre de Santé de Référence Rutshuru, Rutshuru, Nord-Kivu, Congo, The Democratic Republic of the|Centre de Santé Foyer Social, Kabondo, Tshopo, Congo, The Democratic Republic of the	https://ClinicalTrials.gov/show/NCT02940756
290	Malaria Challenge With NF54 Strain	Completed	No Results Available	Plasmodium Falciparum Infection	Biological: NF54 P. falciparum isolate	University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States	https://ClinicalTrials.gov/show/NCT00744133
291	A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection	Completed	Has Results	Cure Rate	Drug: KAE609	Novartis Investigative Site, Ratchabari, Thailand|Novartis Investigative Site, Srisaket, Thailand|Novartis Investigative Site, Tak, Thailand|Novartis Investigative Site, Hanoi, Vietnam	https://ClinicalTrials.gov/show/NCT01860989
292	OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation	Completed	Has Results	Malaria	Drug: OZ439	Mae Ramat District hospital, Mae Ramat, Tak, Thailand|Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand|Faculty of Tropical Medicine,, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT01713621
293	Mefloquine Bioequivalence Among 3 Commercially Available Tablets.	Completed	No Results Available	Malaria		Apoyo Hospital, Iquitos, Peru	https://ClinicalTrials.gov/show/NCT00544024
294	Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day	Completed	No Results Available	Plasmodium Falciparum Infection	Drug: Artemether-lumefantrine 3 days|Drug: Artemether-lumefantrine 5 days	Medical Action Myanmar, Yangon, Myanmar	https://ClinicalTrials.gov/show/NCT02020330
295	Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin	Completed	No Results Available	Malaria	Drug: Fosmidomycin-clindamycin	Medical Research Unit, Lambaréné, Lambaréné, Moyen Ogooué, Gabon	https://ClinicalTrials.gov/show/NCT00217451
296	Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine	Completed	No Results Available	Instantaneous Clearance	Drug: Artemether/lumefantrine	Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT01998295
297	Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine	Completed	No Results Available	Malaria	Biological: AMA1-C1/Alhydrogel + CPG 7909 (Saline)|Biological: AMA1-C1/Alhydrogel + CPG 7909 (Phosphate)|Drug: AMA1-C1/Alhydrogel + CPG 7909	Johns Hopkins University Bloomberg School of Public Health, Washington, D.C., District of Columbia, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT00427167
298	Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana	Completed	No Results Available	Pregnancy Complicated by Malaria as Antepartum Condition	Drug: artesunate-amodiaquine|Drug: Dihydroartemisinin-piperaquine	St.Michael's Hospital, Pramso, Kumasi, Ashanti Region, Ghana	https://ClinicalTrials.gov/show/NCT01231113
299	Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)	Completed	No Results Available	Healthy Volunteer|HV	Drug: AMA1-C1/Alhydrogel + CpG 7909	National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pi, Bethesda, Maryland, United States|University of Rochester, Rochester, New York, United States	https://ClinicalTrials.gov/show/NCT00340574
300	Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar	Suspended	No Results Available	Malaria	Drug: artesunate + amodiaquine	Kivunge Cottage Hospital, Kivunge, North A District, Zanzibar, Tanzania	https://ClinicalTrials.gov/show/NCT00465257
301	Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children	Terminated	No Results Available	Malaria	Drug: Sulfadoxine Pyrimethamine	Medical Research Unit of the Albert Schweitzer Hospital, Lambaréné, Moyen Ogooué, Gabon	https://ClinicalTrials.gov/show/NCT00453856
302	Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Brazil	Terminated	No Results Available	Malaria	Drug: Artemether-Lumefantrine|Drug: Mefloquine- Artesunate	Hospital Geral Maternidade de Cruzeiro do Sul, Cruzeiro do Sul, Acre, Brazil|Centro de Pesquisa em Patologias Tropicais, Porto Velho, Rondonia, Brazil	https://ClinicalTrials.gov/show/NCT01082731
303	Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant	Completed	No Results Available	Malaria	Biological: MSP1 42-C1/Alhydrogel|Biological: CPG 7909	Center for Immunization Research, Johns Hopkins University, Bloomberg School of Public Health, Washington, District of Columbia, United States	https://ClinicalTrials.gov/show/NCT00320658
304	Treatment of Uncomplicated Malaria in Benin	Completed	No Results Available	Uncomplicated Malaria	Drug: sulfadoxine-pyrimethamine|Drug: artemether-lumefantrine|Drug: amodiaquine-artesunate coformulation	Centre de santé, Allada, Benin	https://ClinicalTrials.gov/show/NCT00460369
305	Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria	Completed	No Results Available	Malaria	Drug: AMA1-C1/Alhydrogel + CPG 7909 Vaccine	Doneguebougou Malaria Vaccine Center, Doneguebougou, Mali	https://ClinicalTrials.gov/show/NCT00414336
306	Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children	Recruiting	No Results Available	Plasmodium Falciparum	Drug: Arterolane-piperaquine|Drug: Arterolane-piperaquine+mefloquine|Drug: Artemether-lumefantrine	Kilifi County Hospital, Kilifi, Kenya	https://ClinicalTrials.gov/show/NCT03452475
307	Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy	Completed	No Results Available	Malaria	Drug: Quinine|Drug: artemether / lumefantrine	Epicentre, Mbarara, Mbarara District, Uganda	https://ClinicalTrials.gov/show/NCT00495508
308	Malaria Vaccine for Children in Mali	Completed	No Results Available	Malaria|Malaria Infection	Drug: AMA1-C1/Alhydrogel plus CPG 7909	Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00740090
309	Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance	Completed	No Results Available	Malaria	Drug: Artesunate|Drug: Amodiaquine	Sanofi-Aventis, Yaounde, Cameroon|Sanofi-Aventis, Dakar, Senegal	https://ClinicalTrials.gov/show/NCT00445796
310	Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate	Unknown status	No Results Available	Malaria	Drug: amodiaquine-artesunate versus amodiaquine	University for Development Studies, Tamale, Northern Region, Ghana	https://ClinicalTrials.gov/show/NCT00238017
311	Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru	Completed	No Results Available	Malaria	Drug: Dihydroartemisin-piperaquine|Drug: Mefloquine + Artesunate		https://ClinicalTrials.gov/show/NCT00373607
312	Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults	Completed	No Results Available	Malaria	Biological: FMP012 with AS01B adjuvant system|Other: P falciparum Controlled Human Malaria Infection (CHMI)	Clinical Trials Center, WRAIR, Silver Spring, Maryland, United States	https://ClinicalTrials.gov/show/NCT02174978
313	Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria	Completed	No Results Available	Malaria	Drug: artesunate and mefloquine	Centre Mère et Enfant, Fondation Chantal Biya, Yaounde, Cameroon	https://ClinicalTrials.gov/show/NCT00978172
314	Malaria Vaccine in Children in Mali	Completed	No Results Available	Malaria	Drug: AMA1-C1/Alhydrogel Malaria Vaccine	Bancoumana Clinical Trial Center, Bancoumana, Mali|Doneguebougou Malaria Vaccine Center, Doneguebougou, Mali	https://ClinicalTrials.gov/show/NCT00341250
315	Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children	Completed	No Results Available	Malaria	Drug: Fosmidomycin|Drug: clindamycin	Medical Research Unit, Lambaréné, Lambaréné, Moyen Ogooué, Gabon	https://ClinicalTrials.gov/show/NCT00214643
316	NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1	Active, not recruiting	No Results Available	Plasmodium Falciparum	Biological: NMRC-M3V-Ad-PfCA|Biological: NMRC-MV-Ad-PfC, NMRC-MV-Ad-PfA	Naval Medical Research Center (NMRC) Clinical Trials Center, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT00392015
317	Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria	Terminated	No Results Available	Malaria	Drug: Artesunate plus sulfadoxine-pyrimethamine	Ndlavela Health Centre, Ndlavela, Maputo, Mozambique	https://ClinicalTrials.gov/show/NCT00331708
318	A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya	Completed	No Results Available	Malaria	Biological: Plasmodium falciparum Malaria Protein 010 (FMP010)	Department of Clinical Trials, WRAIR, Silver Spring, Maryland, United States|USAMRU-K/ KEMRI. Walter Reed Project, Kombewa, Kisumu, Nyanza Province, Kenya	https://ClinicalTrials.gov/show/NCT00666380
319	Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women	Completed	No Results Available	Malaria|Pregnancy	Drug: Amodiaquine|Drug: Sulphadoxine-pyrimethamine|Drug: Chloroquine		https://ClinicalTrials.gov/show/NCT00131703
320	Kintampo Trial of Combination Therapy for Malaria	Completed	No Results Available	Malaria	Drug: artesunate-amodiaquine|Drug: coartem|Drug: artesunate-lapdap	Kintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana	https://ClinicalTrials.gov/show/NCT00119145
321	Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function	Terminated	No Results Available	Malaria|Falciparum	Drug: Artemether-lumefantrine		https://ClinicalTrials.gov/show/NCT00386750
322	Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoire	Completed	No Results Available	Malaria	Drug: Artesunate + Amodiaquine	Investigational Site Number 1, Agboville district, Côte D'Ivoire	https://ClinicalTrials.gov/show/NCT01023399
323	Experimental Vaccine for Malaria	Completed	No Results Available	Malaria	Drug: AMA1/Alhydrogel	National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT00114010
324	Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function	Completed	Has Results	Malaria|Falciparum	Drug: Artesunate-mefloquine|Drug: Atovaquone-proguanil|Drug: Artemether-lumefantrine	Novartis Investigational Site, Tumaco, Colombia	https://ClinicalTrials.gov/show/NCT00444106
325	Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia	Recruiting	No Results Available	Pneumonia, Bacterial|Viral Infection|Clinical Pneumonia|Plasmodium Falciparum Malaria|Malaria|Infections, Respiratory		Boston University School of Public Health, Boston, Massachusetts, United States|Basse Field Station, Medical Research Council Gambia Unit, Basse Santa Su, URR, Gambia|Laboratory of Transnational Immunology, UMC Utrecht, Utrecht, Netherlands	https://ClinicalTrials.gov/show/NCT03996967
326	Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in Emergencies	Completed	No Results Available	Malaria	Other: Insecticide Treated Polyethylene Sheeting|Other: Untreated Plastic Sheeting	The Mentor Initiative, Freetown, Sierra Leone	https://ClinicalTrials.gov/show/NCT01456858
327	Artemisinin Resistance in Bangladesh	Completed	No Results Available	Malaria	Drug: Artesunate|Drug: quinine-doxycycline	Bandarban Sadar Hospital, Bandarban Sadar, Bandarban, Bangladesh	https://ClinicalTrials.gov/show/NCT00639873
328	Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A	Unknown status	No Results Available	Malaria	Drug: Artemether-lumefantrine|Drug: Dihydroartemisinin-piperaquine	Bandim Health Project, Bissau, Guinea-Bissau	https://ClinicalTrials.gov/show/NCT01704508
329	Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children	Completed	No Results Available	Malaria	Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049	GSK Investigational Site, Lambaréné, Gabon	https://ClinicalTrials.gov/show/NCT00307021
330	Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants	Completed	Has Results	Malaria	Biological: RTS,S/AS02D|Biological: Engerix-B®|Biological: TETRActHib™	GSK Investigational Site, Dar-es-Salaam, Tanzania	https://ClinicalTrials.gov/show/NCT00289185
331	Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa	Terminated	Has Results	Asymptomatic Parasitemia In Pregnancy	Drug: Azithromycin plus chloroquine	Centre de Sante d'AHOUANSORI -AGUE, Cotonou, Benin|Hôpital Bethesda, Cotonou, Benin|Siaya District Hospital, Siaya, Kenya|Zomba Central Hospital, Zomba, Malawi|Teule Hospital, Muheza, Tanga, Tanzania|National Institute for Medical Research (Mwanza Centre)/ Nyamagana District Hospital, Mwanza, Tanzania|Mulanda Health Centre IV, Kampala, Uganda	https://ClinicalTrials.gov/show/NCT01103713
332	Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children	Completed	Has Results	Malaria	Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049|Biological: Rabipur	GSK Investigational Site, Kintampo, Ghana|GSK Investigational Site, Kumasi, Ghana	https://ClinicalTrials.gov/show/NCT00360230
333	Optimal Fluid Management in Adult Severe Malaria	Completed	No Results Available	Malaria|Sepsis		Chittagong Medical College Hosiptal, Chittagong, Bangladesh	https://ClinicalTrials.gov/show/NCT01936766
334	ACT for the Home Management in Malagasy Children	Completed	No Results Available	Fever|Suspected Malaria	Drug: Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam)	Institut Pasteur, Paris, France	https://ClinicalTrials.gov/show/NCT00612547
335	Apheresis to Obtain Plasma and White Blood Cells in Malies	Withdrawn	No Results Available	Malaria			https://ClinicalTrials.gov/show/NCT01511601
336	Phase II Artesunate Study in Severe Malaria	Completed	No Results Available	Malaria	Drug: Artesunate	Albert Schweitzer Hospital, Lambaréné, Gabon|Universite de Medecine et Science de la Sante, Libreville, Gabon|Queen Elizabeth Central Hospital, Blantyre, Malawi	https://ClinicalTrials.gov/show/NCT00522132
337	Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the Womb	Completed	No Results Available	Malaria		Malaria Research and Training Center, Bamako, Mali	https://ClinicalTrials.gov/show/NCT00772642
